https://www.pharmaceutical-business-review.com/news/astrazeneca-to-pay-110m-to-settle-texas-whistleblower-drug-lawsuits/ 2018-08-10T04:45:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Astratab.jpg https://www.pharmaceutical-business-review.com/news/spark-therapeutics-reports-mixed-results-from-hemophilia-gene-therapy-trial/ 2018-08-10T04:45:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Spark-scientist.jpg https://www.pharmaceutical-business-review.com/news/oxford-biomedica-forms-three-way-partnership-for-cystic-fibrosis-treatment/ 2018-08-10T04:45:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/JohnDawson.jpg https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-designation-to-selumetinib-to-treat-neurofibromatosis-type-1/ 2018-08-10T04:47:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/tabtreat.jpg https://www.pharmaceutical-business-review.com/news/summits-ridinilazole-preserves-gut-microbiome-of-patients-with-c-difficile-infection/ 2018-08-10T04:47:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-2.jpg https://www.pharmaceutical-business-review.com/news/celtaxsys-cf-drug-acebilustat-reduces-pulmonary-exacerbations-in-phase-2-trial/ 2018-08-10T04:48:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/CysticFibrosis.jpg https://www.pharmaceutical-business-review.com/news/karuna-raises-42m-to-advance-karxt-into-phase-2-study/ 2018-08-10T04:51:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-2.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-alnylams-onpattro-to-treat-polyneuropathy-of-hattr-amyloidosis/ 2018-08-13T07:39:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Onpattro.jpg https://www.pharmaceutical-business-review.com/news/samsung-bioepis-to-start-phase-1-trial-of-pancreatitis-drug-sb26samsung-bioepis-to-launch-phase-1-trial-of-pancreatitis-drug-sb26/ 2018-08-13T09:01:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-3.jpg https://www.pharmaceutical-business-review.com/news/camber-pharmaceuticals-voluntarily-recalls-valsartan-tablets-in-us/ 2018-08-13T09:02:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/pills-tablets.jpg https://www.pharmaceutical-business-review.com/news/aralez-pharmaceuticals-agrees-to-sell-main-operating-businesses/ 2018-08-14T08:08:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/business-deal-generic-jul-23-1.jpg https://www.pharmaceutical-business-review.com/news/ahf-files-petition-for-review-of-gilead-aids-drug-patent-case-with-us-supreme-court/ 2018-08-14T09:45:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Gavelimage.jpg https://www.pharmaceutical-business-review.com/news/onspiras-bronchiolitis-obliterans-treatment-secures-fda-orphan-drug-status/ 2018-08-15T01:05:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/FDA-Bldg.jpg https://www.pharmaceutical-business-review.com/news/inovio-doses-first-patient-in-hiv-vaccine-trial/ 2018-08-15T01:10:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/clinical-trial-generic-july-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-sun-pharmas-cequa-for-treatment-of-dry-eye-disease/ 2018-08-16T08:01:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/sun-pharma-building.jpg https://www.pharmaceutical-business-review.com/news/merck-eisai-win-fda-approval-for-lenvima-to-treat-unresectable-hcc/ 2018-08-17T07:39:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Eisai_Head.jpg https://www.pharmaceutical-business-review.com/news/wuxi-apptec-cyclica-collaborate-to-advance-drug-discovery-programs/ 2018-08-17T13:57:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Wuxi.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-to-develop-mrna-based-vaccines-for-influenza/ 2018-08-17T13:58:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Bionech.jpg https://www.pharmaceutical-business-review.com/news/novocure-us-oncology-collaborate-on-advanced-pancreatic-cancer-trial/ 2018-08-17T13:58:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/labequip.jpg https://www.pharmaceutical-business-review.com/news/izana-begins-phase-ii-proof-of-concept-study-of-spinal-arthritis-drug/ 2018-08-17T13:59:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Spinestudy.jpg https://www.pharmaceutical-business-review.com/news/orchard-therapeutics-raises-150m-to-advance-gene-therapies-for-rare-diseases/ 2018-08-17T14:01:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/dna-generic.jpg https://www.pharmaceutical-business-review.com/news/roches-xolair-gets-fda-breakthrough-status-for-food-allergies/ 2018-08-17T14:01:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/immunocore-initiates-phase-1-study-of-imcnyeso-in-patients-with-solid-tumors/ 2018-08-20T07:58:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-1-1.jpg https://www.pharmaceutical-business-review.com/news/ac-immune-reports-clinical-milestones-for-aci-24-vaccine-in-alzheimers-disease-and-down-syndrome/ 2018-08-21T09:07:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Trialdisease.jpg https://www.pharmaceutical-business-review.com/news/pfizer-astellas-amend-clinical-research-protocols-for-two-phase-3-trials-of-enzalutamide/ 2018-08-23T07:46:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Pfizernew.jpg https://www.pharmaceutical-business-review.com/news/abbvie-tolero-to-collaborate-on-acute-myeloid-leukemia-trial/ 2018-08-23T12:35:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/AbbVieHQ.jpg https://www.pharmaceutical-business-review.com/news/schott-to-expand-production-of-prefillable-polymer-syringes/ 2018-08-23T12:37:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/schott-toppac-spritzen.jpg https://www.pharmaceutical-business-review.com/news/study-finds-new-drug-treatment-could-reduce-liver-transplants/ 2018-08-23T12:37:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/liver-article.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-signs-350m-deal-with-kelun-biotech-for-ex-china-rights-to-a167/ 2018-08-23T12:40:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/cancer-cell-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/sensorion-secures-approval-to-start-sens-401-phase-2-trial-in-sudden-sensorineural-hearing-loss/ 2018-08-23T12:41:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-2-1.jpg https://www.pharmaceutical-business-review.com/news/rexahn-partners-with-merck-on-combo-study-in-tnbc/ 2018-08-23T12:42:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Keytruda-trial.jpg https://www.pharmaceutical-business-review.com/news/scientists-discover-potential-druggable-target-for-lung-cancer-treatment/ 2018-08-23T12:44:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/cancer-research-lung-cancer-lab.jpg https://www.pharmaceutical-business-review.com/news/apogen-biotechnologies-expands-series-a-financing-to-11m/ 2018-08-24T07:45:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Apogen.jpg https://www.pharmaceutical-business-review.com/news/bluebird-bio-gritstone-partner-to-develop-cancer-cell-therapies/ 2018-08-24T07:48:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/cancer-cell-generic.jpg https://www.pharmaceutical-business-review.com/news/novartis-to-pay-eur95m-to-galapagos-and-morphosys-for-skin-drug-rights/ 2018-08-26T15:32:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-lillys-osteoarthritis-pain-drug-meets-co-primary-endpoints-in-phase-3-study/ 2018-08-26T15:39:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Pfizernew.jpg https://www.pharmaceutical-business-review.com/news/eusa-pharma-to-buy-global-rights-of-janssens-sylvant-for-115m/ 2018-08-26T15:47:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/800px-JohnsonJohnson_HQ_building.jpg https://www.pharmaceutical-business-review.com/news/clinigen-acquires-global-rights-to-proleukin-outside-us/ 2018-08-26T15:54:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-5.jpg https://www.pharmaceutical-business-review.com/news/roches-baloxavir-marboxil-succeeds-in-phase-iii-flu-study/ 2018-08-26T15:58:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/RocheBasel.jpg https://www.pharmaceutical-business-review.com/uncategorized/indivior-wins-us-court-order-blocking-dr-reddys-sale-of-generic-opioid-treatment/ 2018-08-26T16:05:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Courrt20order1.jpg https://www.pharmaceutical-business-review.com/news/siga-technologies-gets-fda-nod-for-tpoxx-to-treat-smallpox/ 2018-08-26T16:12:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/otsuka-pharmaceutical-to-buy-biotechnology-firm-visterra-for-430m/ 2018-08-26T16:21:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Visterra1.jpg https://www.pharmaceutical-business-review.com/news/us-ftc-approves-takedas-62bn-acquisition-of-shire/ 2018-08-26T16:26:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/TakedaHp.jpg https://www.pharmaceutical-business-review.com/news/biocryst-terminates-merger-deal-with-idera-pharmaceuticals/ 2018-08-26T16:30:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-6.jpg https://www.pharmaceutical-business-review.com/uncategorized/amryt-secures-funding-approval-from-nhs-england-for-bad-cholesterol-treatment/ 2018-08-26T16:34:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/NHS_England_HQ1.jpg https://www.pharmaceutical-business-review.com/news/ema-recalls-certain-heart-drugs-containing-valsartan-over-safety-fears/ 2018-08-26T16:39:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/generic-pills.jpg https://www.pharmaceutical-business-review.com/news/axovant-benitec-sign-licensing-deal-for-axo-aav-opmd-program/ 2018-08-26T16:41:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/PBPN11.jpg https://www.pharmaceutical-business-review.com/news/alliance-pharma-secures-uk-approval-for-nausea-drug-diclectin/ 2018-08-26T16:45:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-7.jpg https://www.pharmaceutical-business-review.com/news/zynerba-halts-development-of-thc-prodrug-zyn001/ 2018-08-26T16:48:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-8.jpg https://www.pharmaceutical-business-review.com/news/ema-accepts-clovis-application-for-expanded-indication-of-rubraca-to-treat-ovarian-cancer/ 2018-08-26T16:50:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Ovarian20cancer1.jpg https://www.pharmaceutical-business-review.com/news/anavex-gets-approval-to-begin-phase-2b-3-trial-of-alzheimers-disease-treatment/ 2018-08-26T16:57:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Anavextrial1.jpg https://www.pharmaceutical-business-review.com/news/aveo-novartis-scrap-326m-antibody-licensing-deal/ 2018-08-26T16:59:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/catalent-to-buy-juniper-pharmaceuticals-in-133m-deal/ 2018-08-26T17:03:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Juniper1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-regulatory-approvals-for-two-cancer-drugs-in-japan/ 2018-08-26T17:06:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/AstraJapan1.jpg https://www.pharmaceutical-business-review.com/news/boehringer-lilly-diabetes-drug-tradjenta-succeeds-in-cardiovascular-outcome-trial/ 2018-08-27T03:58:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-shires-hereditary-angioedema-drug-takhzyro/ 2018-08-27T04:09:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Shire_location_in_Lexington_MA.jpg https://www.pharmaceutical-business-review.com/news/bayer-secures-approval-in-eu-for-xarelto-for-patients-with-coronary-or-peripheral-artery-diseaseec-approves-bayers-xarelto-combo-therapy-to-treat-patients-with-coronary-or-peripheral-arterial-disease/ 2018-08-27T04:33:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Luftbilder_Bayer.jpg https://www.pharmaceutical-business-review.com/news/perrigo-board-approves-separation-of-prescription-pharmaceuticals-business/ 2018-08-27T11:01:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/pills-tablets.jpg https://www.pharmaceutical-business-review.com/news/uks-mhra-grants-early-access-to-alnylams-patisiran/ 2018-08-27T12:07:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Onpattro.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-dompes-oxervate-to-treat-neurotrophic-keratitis/ 2018-08-28T05:12:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Dompe.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-copd-treatment-bevespi-aerosphere-fails-to-succeed-in-phase-i-trial/ 2018-08-28T05:12:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Copd.jpg https://www.pharmaceutical-business-review.com/news/jwp-out-licenses-atopic-dermatitis-drug-jw1601-to-leo-in-402m-deal/ 2018-08-28T09:03:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Leo_Pharma-e1535291905948.jpg https://www.pharmaceutical-business-review.com/news/lupin-introduces-contraceptive-drug-in-us/ 2018-08-28T09:04:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/contraceptive.jpg https://www.pharmaceutical-business-review.com/news/mxc-gets-approval-for-phase-2-trial-of-marijuana-based-cognicann-in-dementia/ 2018-08-29T10:09:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/CogniCann.jpg https://www.pharmaceutical-business-review.com/news/ics-inaugurates-new-3pl-pharmaceutical-distribution-center-in-us/ 2018-08-30T08:32:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/tablets-generic-aug.jpeg https://www.pharmaceutical-business-review.com/news/data-science-company-ixico-extends-contract-with-biopharmaceutical-firm/ 2018-08-31T09:17:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Alzheimers.jpg https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-to-buy-adapt-pharma-in-735m-deal/ 2018-08-31T13:32:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Radnor.jpg https://www.pharmaceutical-business-review.com/news/kandy-therapeutics-raises-25m-to-advance-non-hormonal-drug-candidate/ 2018-08-31T13:33:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/business-deal-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/pfizer-halts-two-trials-of-dmd-drug-domagrozumab/ 2018-08-31T13:33:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Pfizerhq5.jpg https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-trovagenes-onvansertib-for-aml-treatment/ 2018-08-31T13:34:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/EC-building.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-raises-85m-to-accelerate-growth-of-therapeutic-pipeline/ 2018-08-31T13:34:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Harbourmed.jpg https://www.pharmaceutical-business-review.com/news/novartis-kymriah-car-t-cell-therapy-secures-european-approval/ 2018-08-31T13:34:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/sonoma-pharmaceuticals-hoci-demonstrates-positive-effect-in-acne-study/ 2018-08-31T13:35:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/HOCL.jpg https://www.pharmaceutical-business-review.com/news/genentech-affimed-sign-5bn-cancer-dealgenentech-affimed-enter-into-5bn-cancer-deal/ 2018-08-31T13:36:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Genentech.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-tetraphases-xerava-for-complicated-intra-abdominal-infections/ 2018-08-31T13:36:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Tetraphase.png https://www.pharmaceutical-business-review.com/news/shire-completes-2-4bn-sale-of-oncology-business-to-servier/ 2018-09-03T08:40:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Shire_location_in_Lexington_MA.jpg https://www.pharmaceutical-business-review.com/news/merck-secures-fda-approval-for-two-hiv-drugs/ 2018-09-04T06:03:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/DELSTRIGO.jpg https://www.pharmaceutical-business-review.com/news/boehringer-tsinghua-university-to-develop-immunological-therapies-for-infectious-diseases/ 2018-09-05T13:35:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/boehringer-0902_10.jpg https://www.pharmaceutical-business-review.com/news/redx-gets-approval-to-re-start-phase-1-2a-clinical-study-for-porcupine-inhibitor/ 2018-09-05T13:43:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Redx.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-bayers-jivi-for-hemophilia-a-patients-aged-12-and-older/ 2018-09-05T13:43:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Luftbilder_Baye.jpg https://www.pharmaceutical-business-review.com/news/olon-purchases-api-manufacturing-facility-in-india/ 2018-09-05T13:43:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/tablets-generic.jpg https://www.pharmaceutical-business-review.com/news/evotec-chdi-foundation-expand-collaboration-for-huntingtons-disease/ 2018-09-05T13:44:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Tech.jpg https://www.pharmaceutical-business-review.com/news/sunovion-fails-fda-approval-dasotraline/ 2018-09-05T13:45:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/sunovion-media-loebel.jpg https://www.pharmaceutical-business-review.com/news/aurobindo-sandoz-us-novartis-900m/ 2018-09-06T08:03:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/richard-francis.jpg https://www.pharmaceutical-business-review.com/news/sanofi-ec-approval-cablivi/ 2018-09-06T08:08:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Sanofi.jpg https://www.pharmaceutical-business-review.com/news/biothera-pharmaceuticals-enters-into-immuno-oncology-clinical-trial-collaboration-with-astrazeneca/ 2018-09-06T10:46:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Labtrial.jpg https://www.pharmaceutical-business-review.com/news/gilead-galapagos-filgotinib-ankylosing-spondylitis/ 2018-09-07T08:03:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/spondy.jpg https://www.pharmaceutical-business-review.com/news/summit-discovers-new-mechanism-antibiotics-to-combat-eskape-pathogen-targets/ 2018-09-07T10:11:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/clinical-research-lab-generic-1.jpg https://www.pharmaceutical-business-review.com/news/us-hospital-groups-establish-not-for-profit-generic-drug-company/ 2018-09-07T10:15:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/generic.jpg https://www.pharmaceutical-business-review.com/news/keytruda-priority-review-merkel-cell-carcinoma/ 2018-09-07T13:06:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Key100mg.jpg https://www.pharmaceutical-business-review.com/news/fulcrum-raises-80m-funding-to-advance-rare-disease-focused-pipeline/ 2018-09-07T13:07:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/business-deal-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/roches-alecensa-approval-china/ 2018-09-10T05:37:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Shangai.jpg https://www.pharmaceutical-business-review.com/news/haplogen-bayer-enter-into-drug-discovery-and-development-collaboration/ 2018-09-10T06:13:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/bayer-hq.jpeg https://www.pharmaceutical-business-review.com/news/genmab-immatics-to-develop-next-generation-bispecific-cancer-immunotherapies/ 2018-09-10T06:22:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/genmab-cph1.jpg https://www.pharmaceutical-business-review.com/news/marken-opens-customer-solutions-center-in-russia/ 2018-09-10T06:34:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/clinical-logistics.jpg https://www.pharmaceutical-business-review.com/news/can-fite-enrolls-first-patient-in-phase-3-trial-of-piclidenoson-in-psoriasis/ 2018-09-10T06:56:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-2-2.jpg https://www.pharmaceutical-business-review.com/news/teva-regenerons-fasinumab-succeeds-in-phase-3-osteoarthritis-trial/ 2018-09-10T06:56:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Teva-SicorBio.jpg https://www.pharmaceutical-business-review.com/news/purdue-to-pay-assertio-62m-to-settle-patent-infringement-lawsuit/ 2018-09-10T07:31:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/lawsuit-generic.jpeg https://www.pharmaceutical-business-review.com/news/ccab-immunobiochem-collaborate-to-advance-novel-breast-cancer-therapeutic/ 2018-09-10T07:32:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Immunobiochem.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-opdivo-to-treat-metastatic-sclc/ 2018-09-10T07:32:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/BMSbuild.jpg https://www.pharmaceutical-business-review.com/news/scancell-expands-moditope-collaboration-with-karolinska-institute/ 2018-09-10T07:32:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Cancer-cell-1.jpg https://www.pharmaceutical-business-review.com/news/kite-gadeta-collaborate-to-advance-gamma-delta-t-cell-receptor-technology-for-solid-tumors/ 2018-09-10T07:33:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/clinical-trial-generic-july-4.jpg https://www.pharmaceutical-business-review.com/news/leap-therapeutics-to-evaluate-trx518-avelumab-combo-for-advanced-solid-tumors/ 2018-09-10T07:33:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/clinical-trial-generic-july-1.jpg https://www.pharmaceutical-business-review.com/news/biocryst-bags-contract-to-supply-rapivab-antiviral-flu-therapy-doses-to-cdc/ 2018-09-10T08:51:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/CDC_Headquarters_PHIL.jpg https://www.pharmaceutical-business-review.com/news/xspray-pharma-reports-positive-clinical-data-for-hynap-dasa-product-candidate/ 2018-09-10T08:53:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Xspraytrial.jpg https://www.pharmaceutical-business-review.com/news/pci-pharma-services-buys-sherpa-clinical-packaging/ 2018-09-11T07:54:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/PCI-Acquires-Sherpa.jpg https://www.pharmaceutical-business-review.com/news/carlyle-buys-minority-stake-in-us-cdmo-ambio-from-mvm-partners/ 2018-09-11T07:54:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/business-deal-generic-jul-23.jpg https://www.pharmaceutical-business-review.com/news/immunotherapy-firm-oncoresponse-secures-40m-series-b-financing/ 2018-09-12T09:42:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/immuno.jpg https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-accepts-sanofis-dupixent-to-treat-moderate-to-severe-atopic-dermatitis/ 2018-09-12T09:53:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/skindisease.jpg https://www.pharmaceutical-business-review.com/news/ironwood-secures-fda-fast-track-designation-for-heart-drug-praliciguat/ 2018-09-14T07:48:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-subcutaneous-formulation-of-actemra-to-treat-systemic-juvenile-idiopathic-arthritis/ 2018-09-14T09:52:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Gene.jpg https://www.pharmaceutical-business-review.com/news/filgotinib-succeeds-rheumatoid-arthritis/ 2018-09-14T11:45:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Galapos.jpg https://www.pharmaceutical-business-review.com/news/fda-refuses-to-approve-gsks-respiratory-drug-mepolizumab-for-copd/ 2018-09-14T11:51:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia-1.jpg https://www.pharmaceutical-business-review.com/news/beigene-springworks-partner-to-assess-targeted-combination-therapy-in-advanced-solid-tumors/ 2018-09-14T11:52:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/clinical-trial-generic-july.jpg https://www.pharmaceutical-business-review.com/news/drugmaker-gsk-to-cut-650-jobs-in-us/ 2018-09-14T11:53:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-combo-therapy-approved-in-europe/ 2018-09-14T11:57:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Keytruda100mg.jpg https://www.pharmaceutical-business-review.com/news/teva-fda-approval-new-dosage-strength-cassipa/ 2018-09-14T11:58:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-lupus-drug-anifrolumab/ 2018-09-14T12:00:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/lab-astra.jpg https://www.pharmaceutical-business-review.com/news/regeneron-to-invest-800m-in-new-york-expansion/ 2018-09-14T12:01:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Regen.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-tevas-ajovy-for-preventive-treatment-of-migraine/ 2018-09-17T07:51:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/AJOVY-Image.jpg https://www.pharmaceutical-business-review.com/news/actelions-opsumit-improves-pulmonary-vascular-resistance-in-trial-of-portopulmonary-hypertension/ 2018-09-17T10:01:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/chemlab.jpg https://www.pharmaceutical-business-review.com/news/pfizers-jak-inhibitors-alopecia-areata/ 2018-09-18T09:44:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Pfizernew.jpg https://www.pharmaceutical-business-review.com/news/atomwise-signs-evaluation-agreement-with-pfizer/ 2018-09-18T09:48:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Pfizernew-1.jpg https://www.pharmaceutical-business-review.com/news/roivant-launches-new-biopharmaceutical-firm-to-develop-therapeutics-for-respiratory-diseases/ 2018-09-18T09:49:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Respi.jpg https://www.pharmaceutical-business-review.com/news/cellectar-fda-clr-131/ 2018-09-19T07:01:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/cancer-genetics-novellusdx-sign-agreement-to-merge/ 2018-09-19T10:07:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/acquire.jpg https://www.pharmaceutical-business-review.com/news/dasiglucagon-phase-3-trial/ 2018-09-19T10:11:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Zealand-Pharma-president-and-CEO-Britt-Meelby-1.jpg https://www.pharmaceutical-business-review.com/news/ftc-approval-grifols-acquisition/ 2018-09-20T11:27:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Federal_Trade_Commission_Entrance_Doorway-e1537429720555.jpg https://www.pharmaceutical-business-review.com/news/singapore-airlines-pharma-cargo/ 2018-09-21T09:52:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/SIA-acft-a350-3.jpg https://www.pharmaceutical-business-review.com/news/opiant-pharmaceuticals-signs-contract-with-barda-to-accelerate-development-of-nasal-nalmefene-to-treat-opioid-overdose/ 2018-09-21T09:55:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/opioid.jpg https://www.pharmaceutical-business-review.com/news/boehringer-buys-viratherapeutics/ 2018-09-21T11:57:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Boengher.jpg https://www.pharmaceutical-business-review.com/news/accc-arrow-apotex/ 2018-09-21T11:59:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Sims.jpg https://www.pharmaceutical-business-review.com/news/beigene-ges-kubio-facility/ 2018-09-21T12:01:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/BeiGene-KUBio.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-400-jobs-rd-unit/ 2018-09-21T12:02:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Danish-head.jpg https://www.pharmaceutical-business-review.com/news/allergan-bonti/ 2018-09-21T12:05:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/allergan-westport-ireland-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-fda-approval-lumoxiti-hcl/ 2018-09-21T12:06:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/bms-986165-succeeds-phase-2-trial/ 2018-09-21T12:06:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Bristol-Myers-Squibb_Pharmaceutical_Research_Institute-by-Sue-Adair.jpg https://www.pharmaceutical-business-review.com/news/shires-veyvondi-secures-approval-in-europe-for-bleeding-disorder/ 2018-09-21T12:07:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Shire_location_in_Lexington_MA.jpg https://www.pharmaceutical-business-review.com/news/shield-therapeutics-norgine-to-commercialise-feraccru-in-europe-australia-and-new-zealand/ 2018-09-21T12:08:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Shield.jpg https://www.pharmaceutical-business-review.com/news/mylan-adalimumabs-biosimilar-hulio/ 2018-09-24T07:49:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/ECbuild.jpg https://www.pharmaceutical-business-review.com/news/obi-pharma-obi-3424-fda/ 2018-09-24T07:49:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDA-Bldg.jpg https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-supporting-trelegy-elliptas-use-in-broader-group-of-copd-patients/ 2018-09-24T09:15:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg https://www.pharmaceutical-business-review.com/news/lonza-invests-in-swiss-biopark-to-expand-ibex-solutions/ 2018-09-24T09:17:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Lonza_biopark.jpg https://www.pharmaceutical-business-review.com/news/symbiosis-gets-fda-approval-for-manufacturing-fill-finish-process/ 2018-09-25T08:15:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/SYMBIOSIS-Facility.jpg https://www.pharmaceutical-business-review.com/news/farxiga-phase-3-cv-outcomes-trial/ 2018-09-25T08:20:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/astrazeneca-hq-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-lucentis-indication-rop/ 2018-09-25T08:43:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/novartisbasel.jpg https://www.pharmaceutical-business-review.com/news/fda-lifts-clinical-hold-on-sareptas-duchenne-muscular-dystrophy-micro-dystrophin-gene-therapy-program/ 2018-09-25T08:50:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/myelos-acute-radiation-syndrome-therapy-fda/ 2018-09-26T08:56:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDA-Bldg-1.jpg https://www.pharmaceutical-business-review.com/news/gilead-to-launch-generic-hepatitis-c-virus-treatments-in-us/ 2018-09-26T09:24:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Hepatities.jpg https://www.pharmaceutical-business-review.com/news/ibnsina-pharma-selects-infors-solutions-to-streamline-business-operations/ 2018-09-26T09:26:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Ibnsina-Pharma-distribution.jpg https://www.pharmaceutical-business-review.com/news/durvalumab-overall-survival-benefit/ 2018-09-27T08:21:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/astrazeneca-hq-2.jpg https://www.pharmaceutical-business-review.com/news/tris-pharma-nextwave/ 2018-09-27T08:22:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Tris.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-samsung-bioepis-bla-for-humira-biosimilar/ 2018-09-27T09:05:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/kanwa-holdings-to-acquire-midatech-pharma-us/ 2018-09-27T11:06:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/medpharm.jpg https://www.pharmaceutical-business-review.com/news/dova-pharmaceuticals-salix-sign-exclusive-co-promotion-agreement-for-doptelet/ 2018-09-28T09:18:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/salix.jpg https://www.pharmaceutical-business-review.com/news/us-dea-reschedules-gw-pharmaceuticals-epidiolex-to-schedule-v/ 2018-09-28T09:40:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Epilepsy-generic.jpg https://www.pharmaceutical-business-review.com/news/alexion-syntimmune-deal/ 2018-10-01T08:22:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Alexion.jpg https://www.pharmaceutical-business-review.com/news/ksq-therapeutics-secures-80m-funds-to-advance-development-of-oncology-drug-candidates/ 2018-10-01T11:01:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/onco.jpg https://www.pharmaceutical-business-review.com/news/inotrems-nangibotide-yields-positive-results-in-septic-shock-phase-iia-study/ 2018-10-01T11:19:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Inotrem-comunnique-inotrem.png https://www.pharmaceutical-business-review.com/news/recipharm-acquires-sanofi-inhalation-contract-manufacturing-business/ 2018-10-01T15:32:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/handshake.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-sells-antibiotic-manufacturing-site-in-bristol-tennessee/ 2018-10-01T16:36:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/medicine.jpg https://www.pharmaceutical-business-review.com/news/janssen-geron-imetelstat/ 2018-10-02T03:09:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/louis-reed-747388-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/regeneron-skin-cancer-libtayo/ 2018-10-03T08:32:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/skincancer.jpg https://www.pharmaceutical-business-review.com/news/empagliflozin-type-1-diabetes-trial/ 2018-10-05T08:05:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/novartis-boston-pharmaceuticals/ 2018-10-05T08:06:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/roches-tecentriq-lung-cancer/ 2018-10-05T12:15:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/roche-go-therapeutics-cancer-treatment/ 2018-10-05T12:17:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/alliance-pharma-xonvea-uk-launch/ 2018-10-05T12:17:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/pills-generic-oct.jpg https://www.pharmaceutical-business-review.com/news/shield-therapeutics-nda-feraccru/ 2018-10-05T12:17:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/thought-catalog.jpg https://www.pharmaceutical-business-review.com/news/roche-gets-fda-approval-for-hemlibra-for-haemophilia-a-without-factor-viii-inhibitors/ 2018-10-05T12:19:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/mercks-hiv-therapy-delstrigo-achieves-primary-efficacy-endpoint-in-phase-3-study/ 2018-10-05T12:19:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/HIVmerck.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-biktarvy-shows-high-efficacy-in-hiv-study/ 2018-10-05T12:19:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/HIvirus.jpg https://www.pharmaceutical-business-review.com/news/alnylam-seeks-mhra-approval-to-start-aln-aat02-phase-1-2-trial/ 2018-10-05T12:20:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-oct.jpeg https://www.pharmaceutical-business-review.com/news/kite-hifibio-therapeutics-to-develop-technology-for-discovery-of-tcrs-to-treat-cancer/ 2018-10-05T12:20:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Kite.jpg https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-raises-110m-financing-to-achieve-significant-milestones/ 2018-10-05T12:20:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/business-deal-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/sitryx-launches-with-30m-funding-to-develop-disease-modifying-therapeutics/ 2018-10-08T08:59:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/research-lab-generic.jpg https://www.pharmaceutical-business-review.com/news/inovio-develops-dna-encoded-monoclonal-antibody-checkpoint-inhibitor/ 2018-10-09T08:37:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-oct-1.jpeg https://www.pharmaceutical-business-review.com/news/fda-merck-gardasil-9-hpv/ 2018-10-09T09:08:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/new-clinical-trial-for-alzheimers-disease-treatment-begins-in-uk/ 2018-10-10T09:00:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/alzheimers-disease-web.jpg https://www.pharmaceutical-business-review.com/news/stelara-ulcerative-colitis-study/ 2018-10-11T08:36:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/JJbuild.jpg https://www.pharmaceutical-business-review.com/news/maxcyte-begins-first-clinical-trial-in-solid-tumors/ 2018-10-11T08:51:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Tumor.jpg https://www.pharmaceutical-business-review.com/news/mundipharma-buys-spanish-biosimilars-company-cinfa-biotech/ 2018-10-12T08:25:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/mundipharma-facility-1.jpg https://www.pharmaceutical-business-review.com/news/bial-eslicarbazepine-acetate-monotherapy/ 2018-10-12T10:46:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Bial-Portugal-1.jpg https://www.pharmaceutical-business-review.com/news/diurnals-chronocort-phase-3-trial/ 2018-10-12T10:47:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-july.jpg https://www.pharmaceutical-business-review.com/news/fda-ema-multiple-sclerosis-siponimod/ 2018-10-12T10:47:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/novartisbasel.jpg https://www.pharmaceutical-business-review.com/news/mei-beigene-to-evaluate-me-401-zanubrutinib-combo-in-b-cell-malignancies/ 2018-10-12T10:47:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-research-lab-generic.jpg https://www.pharmaceutical-business-review.com/news/silence-therapeutics-launches-interim-european-injunction-application-against-alnylams-onpattro/ 2018-10-12T10:49:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/lawsuit-generic.jpeg https://www.pharmaceutical-business-review.com/news/neurocrine-biosciences-jnana-therapeutics-to-discover-medicines-for-cns-disorders/ 2018-10-12T10:49:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/CNS.jpg https://www.pharmaceutical-business-review.com/news/etherna-immunotherapies-opens-mrna-manufacturing-facility-in-belgium/ 2018-10-12T10:49:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/drugbel.jpg https://www.pharmaceutical-business-review.com/news/hvivo-signs-new-contracts-with-global-biopharmaceutical-firm/ 2018-10-12T10:49:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/contrac.jpg https://www.pharmaceutical-business-review.com/news/carrick-acquires-licensing-rights-of-btgs-ovarian-cancer-drug/ 2018-10-12T10:50:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/business-agreement-signing-generic.jpg https://www.pharmaceutical-business-review.com/news/bms-compugen-com701-opdivo-combo/ 2018-10-15T07:50:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Bristol-Myers-Squibb_Pharmaceutical_Research_Institute-by-Sue-Adair.jpg https://www.pharmaceutical-business-review.com/news/fda-panel-biosimilar-rituxan/ 2018-10-15T07:50:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/bloodcan.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-to-sell-api-manufacturing-business-unit-in-hyderabad-india/ 2018-10-15T10:05:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Acui.jpg https://www.pharmaceutical-business-review.com/news/pci-completes-new-facility-for-clinical-trial-returns-in-uk/ 2018-10-16T07:53:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/PCI-Clinical-Services-Announces-New-Facility-Dedicated-to-Clinical-Trial-Returns_2_LR.jpg https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-submits-nda-to-fda-for-kpi-121-0-25-to-treat-dry-eye-disease/ 2018-10-17T08:22:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Human-eye.jpg https://www.pharmaceutical-business-review.com/news/roches-kadcyla-breast-cancer/ 2018-10-17T10:37:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/RocheBasel-1.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-launches-phase-1-trial-of-ds-1205-in-egfr-mutated-nsclc/ 2018-10-19T15:47:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-july-1.jpg https://www.pharmaceutical-business-review.com/news/abbvie-morphic-therapeutic-to-advance-therapeutic-for-fibrotic-diseases/ 2018-10-19T15:47:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/AbbVieUS.jpg https://www.pharmaceutical-business-review.com/news/revolution-medicines-warp-drive-bio/ 2018-10-19T15:48:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Wapbio.jpg https://www.pharmaceutical-business-review.com/news/lynparza-pancreatic-cancer-fda-orphan/ 2018-10-19T15:49:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/quotient-opens-early-phase-formulation-and-manufacturing-facility-in-us/ 2018-10-19T15:49:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Quotient-Sciences-facility.jpg https://www.pharmaceutical-business-review.com/news/mereo-bps-804-osteogenesis-imperfecta-drug-phase2b-trial/ 2018-10-19T15:49:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-2-2.jpg https://www.pharmaceutical-business-review.com/news/maat-pharma-enrolls-first-patient-in-phase-2-clinical-trial-of-first-in-class-biotherapeutic-to-treat-acute-gvhd/ 2018-10-19T15:50:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/trial.jpg https://www.pharmaceutical-business-review.com/news/alliqua-biomedical-adynxx/ 2018-10-19T15:50:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/adynx.jpg https://www.pharmaceutical-business-review.com/news/hifibio-therapeutics-buys-an-early-stage-biotech-firm-h-immune-therapeutics/ 2018-10-19T15:50:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/early.jpg https://www.pharmaceutical-business-review.com/news/vertex-gets-european-chmp-positive-opinion-for-kalydeco-to-treat-cystic-fibrosis/ 2018-10-22T10:55:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/cystic.jpg https://www.pharmaceutical-business-review.com/news/phase-ii-trial-of-capmatinib-demonstrates-positive-results-in-nsclc/ 2018-10-22T11:02:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/novartis-biopharmaceutical-endocyte/ 2018-10-22T11:10:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/novartis-hq.jpg https://www.pharmaceutical-business-review.com/news/diurnal-adrenal-drug-chronocort-update/ 2018-10-22T11:10:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-2-2-1.jpg https://www.pharmaceutical-business-review.com/news/tp-therapeutics-mezzanine-financing/ 2018-10-23T08:20:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/business-agreement-signing-generic-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-lynparza-ovarian-cancer/ 2018-10-23T08:24:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Astratest.jpg https://www.pharmaceutical-business-review.com/news/eigers-lonafarnib-secures-rpd-designation-from-fda-to-treat-progeria/ 2018-10-23T08:40:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/fsd-pharma-to-acquire-therapix-biosciences/ 2018-10-23T10:57:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/rawpix.jpg https://www.pharmaceutical-business-review.com/news/chinese-pharma-firm-deploys-infortrend-hybrid-cloud-storage-for-rd-data-back-up/ 2018-10-24T09:07:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-july-2.jpg https://www.pharmaceutical-business-review.com/news/canbridge-wuxi-biologics-to-develop-biotherapeutics-for-rare-diseases/ 2018-10-24T09:16:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/rare.jpg https://www.pharmaceutical-business-review.com/news/jj-skincare-firm-ciz/ 2018-10-25T08:40:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/JJbuilding.jpg https://www.pharmaceutical-business-review.com/news/alexion-dicerna-to-discover-rnai-therapies-for-complement-mediated-diseases/ 2018-10-25T08:54:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-research-lab-generic-1.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-signs-clinical-trial-collaboration-deal-with-merck-and-pfizer/ 2018-10-26T08:14:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-july-1-1.jpg https://www.pharmaceutical-business-review.com/news/cipher-pharmaceuticals-launches-brinavess-in-canada/ 2018-10-26T08:47:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/afheart.jpg https://www.pharmaceutical-business-review.com/news/stoke-therapeutics-series-b-financing/ 2018-10-26T08:48:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/business-deal-may-30.jpg https://www.pharmaceutical-business-review.com/news/bain-capital-pfizer-cerevel-therapeutics/ 2018-10-26T08:48:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Pfizer-worldheadquartersentrance-dec.jpg https://www.pharmaceutical-business-review.com/news/halozyme-announces-first-clinical-dosing-in-phase-1-trial-of-bms-986179-with-enhanze-technology/ 2018-10-26T11:24:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Dose.jpg https://www.pharmaceutical-business-review.com/news/fda-roches-xofluza-influenza/ 2018-10-29T06:44:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/RocheBasel-2.jpg https://www.pharmaceutical-business-review.com/news/novartis-brolucizumab-meets-primary-endpoint-in-phase-iii-namd-trial/ 2018-10-29T10:40:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/mayne-pharma-acquires-rights-for-psoriasis-corticosteroid-halobetasol-foam/ 2018-10-29T10:41:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/business-deal-generic-jul-23.jpg https://www.pharmaceutical-business-review.com/news/regeneron-eylea-syringe/ 2018-10-30T06:39:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/eyetest.jpg https://www.pharmaceutical-business-review.com/news/pfizer-novartis-partner-to-advance-treatment-of-nash/ 2018-10-30T11:16:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Pfizerhq5.jpg https://www.pharmaceutical-business-review.com/news/lilly-dicerna-to-collaborate-on-rnai-research-for-several-targets/ 2018-10-30T11:18:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/esperions-bempedoic-acid-phase-3-trial/ 2018-10-31T06:31:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-research-lab-generic-2.jpg https://www.pharmaceutical-business-review.com/news/terns-raises-80m-to-advance-drugs-for-treatment-of-nash-and-cancer/ 2018-10-31T09:20:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/clinical-trial-generic-july-1-2.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-opens-new-biorepository-in-maryland-us/ 2018-10-31T09:43:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Thermo-Fisher-Scientific.jpg https://www.pharmaceutical-business-review.com/news/eqt-karo-pharma-acquisition/ 2018-11-01T05:58:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/karo-pharma-hq.png https://www.pharmaceutical-business-review.com/news/viiv-healthcares-hiv-1-drug-fostemsavir-succeeds-in-phase-3-trial/ 2018-11-01T07:25:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-research-lab-generic.jpg https://www.pharmaceutical-business-review.com/news/gilead-tango-to-partner-on-targeted-immuno-oncology-therapies/ 2018-11-01T10:53:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/cancer-cell-generic.jpg https://www.pharmaceutical-business-review.com/news/grunenthal-nexium-vimovo-rights/ 2018-11-02T06:32:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Gr%C3%BCnenthal-hq.jpg https://www.pharmaceutical-business-review.com/news/verona-enrolls-last-patient-in-phase-2-trial-for-rpl554-in-copd/ 2018-11-02T10:47:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-generic-oct.jpeg https://www.pharmaceutical-business-review.com/news/gw-announces-us-launch-of-cannabinoid-medicine-for-seizures/ 2018-11-02T10:50:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/epidiolex-1.png https://www.pharmaceutical-business-review.com/news/janssen-recalls-ortho-novum-tablets-due-to-incorrect-veridate-dispenser-instructions/ 2018-11-05T11:14:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Janssenortho.jpg https://www.pharmaceutical-business-review.com/news/alexion-wraps-up-1-2bn-acquisition-of-syntimmune/ 2018-11-05T11:15:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/business-shake-hands-sep.jpeg https://www.pharmaceutical-business-review.com/news/sandoz-fda-approval-hyrimoz/ 2018-11-05T11:17:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/novartis-hq-basel-jan.jpg https://www.pharmaceutical-business-review.com/news/pfizer-lung-cancer-lorbrena/ 2018-11-06T09:53:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Pfizerwo.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-files-bla-with-fda-for-lymphoma-drug-adcetris/ 2018-11-06T09:57:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/cancer-cell-generic-1.jpg https://www.pharmaceutical-business-review.com/news/quotient-sciences-expands-formulation-and-manufacturing-operations-in-uk/ 2018-11-06T09:57:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/formula.jpg https://www.pharmaceutical-business-review.com/news/irx-therapeutics-acquired-by-brooklyn-immunotherapeutics/ 2018-11-08T10:58:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/business-agreement-signing-generic.jpg https://www.pharmaceutical-business-review.com/news/glenmark-pharmaceuticals-plans-to-launch-phase-1-trial-in-solid-tumors/ 2018-11-08T11:01:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/tumor.jpg https://www.pharmaceutical-business-review.com/news/4d-pharma-ibs-drug-blautix-phase-2-trial/ 2018-11-09T08:26:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-research-lab-generic-1.jpg https://www.pharmaceutical-business-review.com/news/biotime-asterias-biotherapeutics/ 2018-11-09T08:52:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Biotime.jpg https://www.pharmaceutical-business-review.com/news/shire-liver-diseases-maralixibat/ 2018-11-09T08:53:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Shire_location.jpg https://www.pharmaceutical-business-review.com/news/genkyotex-gkt831-phase-2-trial/ 2018-11-09T09:13:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-generic-oct-1.jpeg https://www.pharmaceutical-business-review.com/news/venclyxto-mabthera-ec-approval/ 2018-11-09T09:13:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/abbvie-hq.jpeg https://www.pharmaceutical-business-review.com/news/arrowhead-janssen-aro-hbv/ 2018-11-09T09:14:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/ArrowHIv.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-covis-pharma-otc-drugs/ 2018-11-09T09:16:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/bms-infinity-opdivo-ipi-549/ 2018-11-09T09:16:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/bladderuro.jpg https://www.pharmaceutical-business-review.com/news/visterra-begins-phase-1-clinical-study-of-monoclonal-antibody-vis649/ 2018-11-09T11:29:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/kidney.jpg https://www.pharmaceutical-business-review.com/news/recursion-secures-nih-phase-2-sbir-grant-to-discover-senolytic-drug-candidates/ 2018-11-09T11:32:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-generic-july.jpg https://www.pharmaceutical-business-review.com/news/ferring-launches-nocdurna-in-us-to-treat-nocturia-due-to-np/ 2018-11-12T08:37:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/nocdurna-1-e1542009633498.jpg https://www.pharmaceutical-business-review.com/news/harpoon-therapeutics-secures-70m-funds-to-advance-immunotherapy-programs/ 2018-11-12T11:04:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/immuno.jpg https://www.pharmaceutical-business-review.com/news/crispr-maxcyte-expand-partnership-to-develop-immuno-oncology-therapies/ 2018-11-13T10:25:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/cancer-cell-generic-2.jpg https://www.pharmaceutical-business-review.com/news/pain-therapeutics-challenges-fda-decision-on-remoxy/ 2018-11-13T10:28:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/scientists-engineer-dna-encoded-monoclonal-antibodies-for-zaire-ebolavirus/ 2018-11-14T10:54:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Ebola-copy.jpg https://www.pharmaceutical-business-review.com/news/nextcure-secures-93m-funds-to-support-clinical-development-of-two-drug-candidates/ 2018-11-14T10:58:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/drugtest.jpg https://www.pharmaceutical-business-review.com/news/abbvies-mavyret-hcv-study/ 2018-11-15T02:43:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/AbbVieUS.jpg https://www.pharmaceutical-business-review.com/news/seattle-genetics-begins-blood-cancer-trial-with-sea-bcma/ 2018-11-15T09:02:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/bloodcancer.jpg https://www.pharmaceutical-business-review.com/news/janssen-applies-for-expanded-approval-for-imbruvica-in-europe/ 2018-11-15T10:00:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/JohnsonJohnson_HQ_building.jpg https://www.pharmaceutical-business-review.com/news/bms-secures-positive-chmp-opinion-for-opdivo-yervoy-combo-in-rcc/ 2018-11-16T09:23:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/BMSbuild.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-synagis-us-rights-sobi/ 2018-11-16T11:00:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/astrazeneca-hq-cambridge.jpg https://www.pharmaceutical-business-review.com/news/nestle-health-science-aimmune/ 2018-11-16T11:00:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Nestle.jpg https://www.pharmaceutical-business-review.com/news/lynparza-priority-review-ovarian-cancer/ 2018-11-16T11:01:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/gs-9674-phase-2-liver-study/ 2018-11-16T11:01:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/liver.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-keynote-181/ 2018-11-16T11:02:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/tecentriq-priority-review-breast-cancer/ 2018-11-16T11:03:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/nexus-pharmaceuticals-gets-fda-nod-for-arsenic-trioxide-injection-in-10mg-per-10ml-vial/ 2018-11-16T11:03:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Arsenic.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-drug-promacta-for-first-line-saa/ 2018-11-19T09:12:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/novartisbasel1.jpg https://www.pharmaceutical-business-review.com/news/aries-pharmaceuticals-gets-fda-nod-for-aemcolo-to-treat-travelers-diarrhea/ 2018-11-20T09:01:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Ecoli.jpg https://www.pharmaceutical-business-review.com/news/gsk-seeks-paediatric-indication-for-nucala-in-severe-eosinophilic-asthma/ 2018-11-20T10:32:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/GlaxoSmithKline_3_Franklin_Plaza_Philadelphia.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-fails-os/ 2018-11-20T10:34:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/trial.jpg https://www.pharmaceutical-business-review.com/news/boehringer-epizyme-oncology-therapy-program/ 2018-11-20T10:34:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Boehnger.jpg https://www.pharmaceutical-business-review.com/news/glycomimetics-uproleselan-phase-3/ 2018-11-21T06:39:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-generic-2.jpg https://www.pharmaceutical-business-review.com/news/pfizer-avelumab-javelin-ovarian/ 2018-11-21T09:38:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Pfizerworldhead.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-gets-favorable-decision-in-buprenorphine-and-naloxone-sublingual-film-patent-case/ 2018-11-21T09:42:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/leo-pharma-pellepharm-form-760m-rare-skin-disease-collaboration/ 2018-11-21T09:43:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/leo-pharma.jpeg https://www.pharmaceutical-business-review.com/news/gamifant-fda-approval-hlh/ 2018-11-22T08:43:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Gamifant_10and50mg_vial_package_v1.jpg https://www.pharmaceutical-business-review.com/news/evotec-immuneering-to-work-on-ai-driven-ligand-identification-for-rare-hereditary-metabolic-diseases/ 2018-11-22T08:47:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/discovery.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-takedas-acquisition-of-shire/ 2018-11-22T08:50:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Shire_location_in_Lexington_MA.jpg https://www.pharmaceutical-business-review.com/news/cambrex-avista-pharma-deal/ 2018-11-23T07:30:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/generic-tablets.jpeg https://www.pharmaceutical-business-review.com/news/pfizer-daurismo-diagnosed-aml/ 2018-11-23T07:32:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/vineti-tessa-partner-to-advance-cancer-immunotherapies/ 2018-11-23T11:08:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/cancer-cell-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/camurus-gets-eu-nod-for-weekly-and-monthly-buvidal-for-opioid-dependence/ 2018-11-23T11:09:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/pill.jpg https://www.pharmaceutical-business-review.com/news/luxturna-gene-therapy-eu-approval/ 2018-11-26T05:35:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Luxturna-product-vial.jpg https://www.pharmaceutical-business-review.com/news/gsk-kyowa-hakko-kirin-to-commercialize-anemia-drug-daprodustat-in-japan/ 2018-11-26T09:12:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/GSKUK.jpg https://www.pharmaceutical-business-review.com/news/poxel-begins-part-2-of-phase-1a-study-for-nash-treatment-pxl065/ 2018-11-26T10:56:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/trial-1.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-fasenra-egpa-fda/ 2018-11-26T13:45:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/astrazeneca-hq-1.jpg https://www.pharmaceutical-business-review.com/news/actinogen-medical-enrolls-last-patient-in-phase-2-alzheimers-trial/ 2018-11-27T09:26:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-research-lab-generic-3.jpg https://www.pharmaceutical-business-review.com/news/mundipharma-neulasta-biosimilar-pelmeg/ 2018-11-27T09:30:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/mundipharma.jpg https://www.pharmaceutical-business-review.com/news/cyclica-bayer-partner-to-advance-drug-discovery-programs/ 2018-11-27T10:56:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/Luftbilder_Bayer.jpg https://www.pharmaceutical-business-review.com/news/181084/ 2018-11-27T11:00:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/plasma.jpg https://www.pharmaceutical-business-review.com/news/roches-genentech-jecure-therapeutics/ 2018-11-28T09:13:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/gene.jpg https://www.pharmaceutical-business-review.com/news/beigene-acquires-rights-to-zymeworks-zw25-and-zw49-bispecific-candidates-in-asia-pacific/ 2018-11-28T09:55:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/hand-shake-generic-nov.jpg https://www.pharmaceutical-business-review.com/news/bms-opdivo-yervoy/ 2018-11-28T10:03:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/lungtrial.jpg https://www.pharmaceutical-business-review.com/news/qps-expands-us-phase-i-clinical-trial-capabilities/ 2018-11-28T10:07:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/QPS.jpg https://www.pharmaceutical-business-review.com/news/teva-celltrion-get-fda-nod-for-biosimilar-to-roches-cancer-drug-rituxan/ 2018-11-29T09:25:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/FDAreseacrh-1.jpg https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-ve202-trial/ 2018-11-29T09:35:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-generic-july-2.jpg https://www.pharmaceutical-business-review.com/news/hookipa-darwinhealth-to-collaborate-on-immunotherapies-development/ 2018-11-29T09:39:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/cancer-generic-cell-nov.jpg https://www.pharmaceutical-business-review.com/news/puretechs-vor-secures-us-patent-for-compositions-and-methods-to-treat-hematologic-malignancies/ 2018-11-29T11:30:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/blood-drop.jpg https://www.pharmaceutical-business-review.com/news/wuxi-abl-bio-to-collaborate-on-multiple-bispecific-antibodies/ 2018-11-30T09:49:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-research-lab-generic-2-1.jpg https://www.pharmaceutical-business-review.com/news/abcellera-autolus-partner-on-antibody-discovery-project/ 2018-11-30T10:46:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Abcellar.jpg https://www.pharmaceutical-business-review.com/news/biopharmaceutical-firm-aprea-therapeutics-raises-e50m-in-financing/ 2018-12-03T09:51:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/cancer-generic-cell-nov.jpg https://www.pharmaceutical-business-review.com/news/novartis-gilenya-ms/ 2018-12-03T09:58:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/novartishead.jpg https://www.pharmaceutical-business-review.com/news/cyxone-ms-drug-t20k-update/ 2018-12-03T09:59:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/clinical-trial-nov.jpg https://www.pharmaceutical-business-review.com/news/crown-laboratories-buys-select-otc-consumer-healthcare-brands-from-gsk/ 2018-12-03T11:04:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/GSKLondon.jpg https://www.pharmaceutical-business-review.com/news/novartis-zolgensma-fda-priority-review/ 2018-12-04T08:35:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/novartis-hq-basel.jpg https://www.pharmaceutical-business-review.com/news/redx-rxc006-treat-fibrosis/ 2018-12-04T08:35:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/lung.jpg https://www.pharmaceutical-business-review.com/news/trigr-therapeutics-abl-bio-sign-license-agreement-for-bispecific-antibody-candidate/ 2018-12-04T09:50:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Trigr.jpg https://www.pharmaceutical-business-review.com/news/momenta-revises-regulatory-strategy-for-proposed-humira-biosimilar/ 2018-12-04T09:55:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/gsk-oncology-tesaro/ 2018-12-05T08:59:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/GSK.jpg https://www.pharmaceutical-business-review.com/news/novartis-initiates-phase-iii-trials-of-ligelizumab-in-urticaria/ 2018-12-05T11:38:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/novartishead.jpg https://www.pharmaceutical-business-review.com/news/ixico-secures-expanded-contract-from-major-biopharmaceutical-firm/ 2018-12-05T11:40:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/rawpixel.jpg https://www.pharmaceutical-business-review.com/news/deepmind-3d-structure-proteins/ 2018-12-05T11:43:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Origami-CASP-181127-r01_fig1-folding.jpg https://www.pharmaceutical-business-review.com/news/tris-pharma-recalls-infants-liquid-ibuprofen-in-us/ 2018-12-06T08:16:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/infants-ibuprofen.jpg https://www.pharmaceutical-business-review.com/news/mereo-biopharma-oncomed-pharmaceuticals-proposes-merger-deal/ 2018-12-06T11:41:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/onco.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-covis-pharma/ 2018-12-07T02:13:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/jjs-darzalex-multiple-myeloma/ 2018-12-07T02:14:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Jhq.jpg https://www.pharmaceutical-business-review.com/news/eisai-ucl-to-launch-phase-i-trials-of-e2814-for-alzheimers-disease/ 2018-12-10T09:52:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/clinical-trial-nov.jpg https://www.pharmaceutical-business-review.com/news/french-pharma-firm-cristers-selects-adents-prodigi-serialisation-solution/ 2018-12-10T11:03:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/drugpill.jpg https://www.pharmaceutical-business-review.com/news/bms-vedanta-biosciences-collaboration/ 2018-12-11T07:54:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Bristol-Myers-Squibb_Pharmaceutical_Research_Institute-by-Sue-Adair-1.jpg https://www.pharmaceutical-business-review.com/news/ucb-uk-research-development/ 2018-12-11T07:59:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/digital-molecule.jpg https://www.pharmaceutical-business-review.com/news/pci-expands-cold-chain-storage-capabilities-at-uk-site/ 2018-12-11T08:02:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Hay-on-Wye-1.jpg https://www.pharmaceutical-business-review.com/news/e-therapeutics-novo-nordisk-enter-into-research-collaboration-agreement/ 2018-12-11T11:12:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/research.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-fails-to-improve-os-in-head-and-neck-cancer-trial/ 2018-12-11T11:21:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Astratrial.jpg https://www.pharmaceutical-business-review.com/news/versant-ventures-launches-new-biotech-firm-black-diamond-therapeutics/ 2018-12-12T09:46:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/cancer-generic-cell-nov-1.jpg https://www.pharmaceutical-business-review.com/news/schrodinger-tb-alliance-collaborate-to-advance-tuberculosis-drug-discovery/ 2018-12-12T11:41:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/drug.jpg https://www.pharmaceutical-business-review.com/news/circassia-astrazenecas-copd-tudorza/ 2018-12-13T09:04:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Astraright.jpg https://www.pharmaceutical-business-review.com/news/alnylam-silence-settlement/ 2018-12-13T09:04:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Onpattro.jpg https://www.pharmaceutical-business-review.com/news/weizmann-researchers-discover-new-neural-mechanism-underlying-anxiety/ 2018-12-13T10:58:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Fainzilber.jpg https://www.pharmaceutical-business-review.com/news/x-chem-almirall-forge-dermatology-focused-drug-discovery-alliance/ 2018-12-13T10:58:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Almirall_Sant_Celoni_2.jpg https://www.pharmaceutical-business-review.com/news/ra-pharma-zilucoplan-phase-2/ 2018-12-13T11:12:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/clinical-trial-nov-1.jpg https://www.pharmaceutical-business-review.com/news/bausch-health-signs-stalking-horse-agreement-to-buy-synergy-pharmaceuticals/ 2018-12-14T10:33:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Baush.jpg https://www.pharmaceutical-business-review.com/news/novartis-gets-ec-approval-for-self-administration-of-xolair-across-all-indications/ 2018-12-17T07:59:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/novartishead.jpg https://www.pharmaceutical-business-review.com/news/amag-pharmaceuticals-perosphere/ 2018-12-17T08:13:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Amag.jpg https://www.pharmaceutical-business-review.com/news/lilly-ac-immune-collaboration/ 2018-12-17T08:14:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/ac-immmune-lab.jpg https://www.pharmaceutical-business-review.com/news/pfizer-gets-positive-chmp-opinion-for-oncology-biosimilar/ 2018-12-17T11:29:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/innovent-incyte-sign-deal-for-three-clinical-stage-product-candidates-in-china/ 2018-12-17T11:31:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Innopate.jpg https://www.pharmaceutical-business-review.com/news/vedanta-bacterial-consortium-candidate/ 2018-12-18T10:08:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Clostridium.png https://www.pharmaceutical-business-review.com/news/teva-reports-positive-results-for-fremanezumab-in-phase-iiib-migraine-trial/ 2018-12-18T10:10:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/TevaCanada2.jpg https://www.pharmaceutical-business-review.com/news/fuji-pharma-acquires-minority-stake-in-alvotech/ 2018-12-18T10:17:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Alvotech_Facilit.jpg https://www.pharmaceutical-business-review.com/news/teva-celltrion-biosimilar-breast/ 2018-12-18T10:23:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/c4xd-horizon-synthetic-lethality-targets/ 2018-12-19T10:45:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/cancer-generic.jpg https://www.pharmaceutical-business-review.com/news/delsitech-innovare-to-develop-long-acting-hiv-therapy/ 2018-12-19T10:47:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/clinical-trial-nov-3.jpg https://www.pharmaceutical-business-review.com/news/amgen-molecular-partners-announce-immuno-oncology-collaboration/ 2018-12-19T10:48:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Amgen.jpg https://www.pharmaceutical-business-review.com/news/taisho-offers-to-buy-bms-upsa-consumer-health-business-for-1-6bn/ 2018-12-20T08:11:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/handBMS.jpg https://www.pharmaceutical-business-review.com/news/gilead-scholar-rock-to-develop-therapies-for-fibrotic-diseases/ 2018-12-20T08:11:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/ID-100475063.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-fibrogen-roxadustat/ 2018-12-20T08:12:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Tablet.jpg https://www.pharmaceutical-business-review.com/news/kuehne-nagel-opens-pharma-and-healthcare-warehouse-in-slovenia/ 2018-12-20T10:45:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Pharma.jpg https://www.pharmaceutical-business-review.com/news/lynparza-solo-3-trial-results/ 2018-12-21T06:02:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/novartis-lfb-group-cellforcure/ 2018-12-21T06:02:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/novartisheadquar.jpg https://www.pharmaceutical-business-review.com/news/pfizer-gsk-consumer-healthcare-jv/ 2018-12-21T06:04:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Pfizerworldheadquarters-Jan.jpg https://www.pharmaceutical-business-review.com/news/gilead-agenus-collaborate-on-development-of-immuno-oncology-therapies/ 2018-12-21T11:24:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/tabgilead.jpg https://www.pharmaceutical-business-review.com/news/astellas-pfizers-xtandi-meets-endpoint-in-phase-3-prostate-cancer-trial/ 2018-12-21T11:31:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Pfizernew.jpg https://www.pharmaceutical-business-review.com/news/lupin-awards-malt1s-licensing/ 2018-12-24T10:08:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/SEM.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-ultomiris/ 2018-12-26T14:07:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Haemolytic.jpg https://www.pharmaceutical-business-review.com/news/scientists-develop-treatment-eye/ 2018-12-26T14:14:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/cornea-.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-kala-nda/ 2018-12-27T13:09:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/daniil.jpg https://www.pharmaceutical-business-review.com/news/researchers-study-genetic-pcos/ 2018-12-27T13:14:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/PCOS.jpg https://www.pharmaceutical-business-review.com/news/opiant-sanofi-licensing-deal/ 2018-12-31T10:34:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/cannobis.jpg https://www.pharmaceutical-business-review.com/news/portola-secures-fda-approval-for-andexxa-generation-2-manufacturing-process/ 2019-01-02T09:33:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/zydus-cadila-usfda-nod/ 2019-01-02T09:40:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Zydus-Biologics-Ahmedabad.jpg https://www.pharmaceutical-business-review.com/news/us-fda-approves-sanofis-new-pediatric-vaccine/ 2019-01-02T09:40:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Sanofi-FDA-28thDec.jpg https://www.pharmaceutical-business-review.com/news/nuvo-pharmaceuticals-completes-acquisition-of-revenue-generating-products-from-aralez-pharmaceuticals/ 2019-01-02T10:41:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Nuvo.jpg https://www.pharmaceutical-business-review.com/news/bms-sprycel-fda-approval/ 2019-01-03T09:42:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Bristol_Myers_Squibb_Moreton_Wirral.jpg https://www.pharmaceutical-business-review.com/news/antengene-funds-cancer-candidates/ 2019-01-03T09:44:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Antigene.jpg https://www.pharmaceutical-business-review.com/news/ironwood-allergan-set-to-resolve-linzess-patent-litigation-with-mylan/ 2019-01-03T09:44:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/allergan-westport-ireland.jpg https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-announces-full-enrollment-of-poziotinib-egfr-cohort-for-previously-treated-nsclc/ 2019-01-03T12:28:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/lungcancer.jpg https://www.pharmaceutical-business-review.com/news/pfizer-alopecia-areata/ 2019-01-04T10:52:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/promethera-investment-itochu/ 2019-01-04T10:54:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/photo-1519120126473-8be7aedcd6c6-2.jpg https://www.pharmaceutical-business-review.com/news/otsuka-click-to-develop-digital-therapeutics-for-mdd/ 2019-01-04T10:57:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100220946.jpg https://www.pharmaceutical-business-review.com/news/deciphera-begins-clinical-trial-of-rebastinib-in-combination-with-carboplatin-for-advanced-or-metastatic-solid-tumors/ 2019-01-04T10:59:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/virus.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-acquisition-celgene/ 2019-01-07T08:36:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/POMALYST-Product-Shot_IMG_2118.jpg https://www.pharmaceutical-business-review.com/news/adaptive-genentech-to-collaborate-on-personalized-cellular-therapies-for-cancer/ 2019-01-07T09:03:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Headquarters_Shot.jpg https://www.pharmaceutical-business-review.com/news/boehringer-exercises-option-on-second-hepatic-disease-target-from-collaboration-with-dicerna/ 2019-01-07T09:06:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Boehnger.jpg https://www.pharmaceutical-business-review.com/news/pci-to-invest-20m-in-biologic-medicines-and-advanced-injectable-delivery-forms/ 2019-01-08T09:22:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/PCI-invests-in-automated-assembly-of-autoinjectors-300dpi.jpg https://www.pharmaceutical-business-review.com/news/gilead-yuhan-nash-partnership/ 2019-01-08T09:24:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/in-the-lab-1-1251082.jpg https://www.pharmaceutical-business-review.com/news/biontech-cancer-research-sanofi/ 2019-01-08T09:25:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/cancerdeal.jpg https://www.pharmaceutical-business-review.com/news/cytoreason-pfizer-collaborate-on-machine-learning-model-of-immune-system-for-drug-discovery/ 2019-01-08T09:33:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/catalent-biologics-capacity-us-sites/ 2019-01-08T11:45:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/drugfill.jpg https://www.pharmaceutical-business-review.com/news/neurobo-to-begin-clinical-trial-of-nb-01-in-adult-patients-with-diabetic-neuropathic-pain/ 2019-01-09T09:08:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/nervous.jpg https://www.pharmaceutical-business-review.com/news/canbridge-wuxi-expand-rare-disease-partnership/ 2019-01-09T10:46:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/photo-1537522067833-5ea8b58ea85a.jpg https://www.pharmaceutical-business-review.com/news/novartis-breakthrough-therapy-status-sickle-cell-disease-treatment-crizanlizumab/ 2019-01-10T06:54:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/novartisheadquar.jpg https://www.pharmaceutical-business-review.com/news/lilly-acquisition-loxo-oncology/ 2019-01-10T06:54:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Lilly-hq.jpg https://www.pharmaceutical-business-review.com/news/elevian-insilico-collaborate-to-discover-drugs-for-aging/ 2019-01-10T09:34:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/drugdiscover.jpg https://www.pharmaceutical-business-review.com/news/eusa-pharma-sylvant/ 2019-01-10T09:35:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Eusa.jpg https://www.pharmaceutical-business-review.com/news/agenus-to-use-selexis-technology-to-produce-therapeutic-proteins/ 2019-01-10T09:35:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/cancer-cell-generic-aug.jpg https://www.pharmaceutical-business-review.com/news/diurnal-secures-second-us-patent-for-chronocort/ 2019-01-11T09:16:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Usptojamesmadisonbuildingsouthside.jpg https://www.pharmaceutical-business-review.com/news/hvivo-achieves-primary-endpoint-in-phase-iib-viral-challenge-study-for-flu-v/ 2019-01-11T09:20:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/virus-1.jpg https://www.pharmaceutical-business-review.com/news/takeda-shire-acquisition-update/ 2019-01-11T09:20:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Shire_location_in_Lexington_MA.jpg https://www.pharmaceutical-business-review.com/news/ascletis-and-alphamab-announce-strategic-collaboration-and-licensing-agreement-for-anti-pd-l1-to-treat-hepatitis-b-and-other-viral-diseases/ 2019-01-14T11:23:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/virus-cell.jpg https://www.pharmaceutical-business-review.com/news/puma-biotechnology-knight-therapeutics-sign-license-deal-to-commercialize-nerlynx-in-canada/ 2019-01-14T11:33:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/deal-1.jpg https://www.pharmaceutical-business-review.com/news/ocular-seeks-fda-nod-for-expanded-indication-of-dextenza-eye-treatment/ 2019-01-15T04:13:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/HUman-eye.jpg https://www.pharmaceutical-business-review.com/news/pfizers-tafamidis-priority-review-attr-cm/ 2019-01-16T08:56:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/exelixis-announces-u-s-fda-approval-of-cabometyx-cabozantinib-tablets-for-previously-treated-hepatocellular-carcinoma/ 2019-01-16T08:57:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/CABOMETYX_60mg_40mg_20mg.jpg https://www.pharmaceutical-business-review.com/news/charles-river-atomwise-drug-discovery/ 2019-01-16T11:23:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/drugcapacity.jpg https://www.pharmaceutical-business-review.com/news/bioharmony-therapeutics-boehringer-ingelheim-to-advance-bacteriophage-lysin-therapeutics-to-treat-f-multi-drug-resistant-bacterial-infection/ 2019-01-16T11:24:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/bacteria.jpg https://www.pharmaceutical-business-review.com/news/luye-pharma-grants-astrazeneca-exclusives-rights-to-promote-xuezhikang-capsules-in-mainland-china/ 2019-01-17T09:02:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/silences-sln124-%ce%b2-thalassemia/ 2019-01-17T09:07:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100277292.jpg https://www.pharmaceutical-business-review.com/news/juvenescence-closes-first-tranche-of-series-b-financing-for-further-growth-and-development/ 2019-01-17T09:07:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/drug.jpg https://www.pharmaceutical-business-review.com/news/sanofi-biomunex-bixab-antibody/ 2019-01-17T09:08:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/therapeutic.jpg https://www.pharmaceutical-business-review.com/news/schott-pharmaceutical-packaging/ 2019-01-18T08:19:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/schott-muellheim-4726x2454-15012019.jpg https://www.pharmaceutical-business-review.com/news/janssen-erleada-ec/ 2019-01-18T08:20:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/JandJ.jpg https://www.pharmaceutical-business-review.com/news/adc-therapeutics-announces-first-patient-dosed-in-phase-i-clinical-trial-of-adct-601-in-advanced-solid-tumors/ 2019-01-18T09:55:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/clinical-trial-nov-3-1.jpg https://www.pharmaceutical-business-review.com/news/vaccinex-announces-completion-of-enrollment-for-signal-huntingtons-disease-trial/ 2019-01-18T09:57:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Hunchington.jpg https://www.pharmaceutical-business-review.com/news/zymeworks-reports-second-investigational-new-drug-ind-submission-milestone-achieved-in-lilly-collaboration/ 2019-01-21T09:49:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/promentis-pharmaceuticals-commences-phase-2-studies-for-sxc-2023-targeting-novel-glutamatergic-mechanism/ 2019-01-21T09:49:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/clinical-trial-nov.jpg https://www.pharmaceutical-business-review.com/news/pci-pharma-services-announces-further-expansion-of-controlled-substance-storage/ 2019-01-22T09:26:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Oxycodone.png https://www.pharmaceutical-business-review.com/news/ec-approves-vertexs-cf-treatment-orkambi-for-children-aged-two-to-five-years/ 2019-01-22T09:27:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ClubbingCF.jpg https://www.pharmaceutical-business-review.com/news/kyn-therapeutics-celgene-collaboration/ 2019-01-22T09:27:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100250735.jpg https://www.pharmaceutical-business-review.com/news/acrotech-hematology-oncology-spectrum/ 2019-01-22T09:28:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/drugonco.jpg https://www.pharmaceutical-business-review.com/news/nash-pharmaceuticals-announces-84-reduction-of-fibrosis-by-additional-lead-compound-in-second-pre-clinical-study-for-non-alcoholic-fatty-liver-disease/ 2019-01-22T09:31:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Liver.jpg https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-announces-clearance-of-ind-for-rp-a501-gene-therapy-for-danon-disease/ 2019-01-23T09:16:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-blincyto-in-patients-with-philadelphia-chromosome-negative-minimal-residual-disease-positive-b-cell-precursor-all/ 2019-01-23T09:36:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Amgenheadquarters.jpg https://www.pharmaceutical-business-review.com/news/redx-pharma-temporarily-stops-rxc004-cancer-trial-to-rectify-patient-dosing-290318-6099853/ 2019-01-23T12:13:59+00:00 https://www.pharmaceutical-business-review.com/news/redx-rxc004-clinical-trial/ 2019-01-23T13:46:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/clinical-trial-generic-1.jpg https://www.pharmaceutical-business-review.com/news/ironwood-pharmaceuticals-initiates-phase-1-trial-of-iw-6463/ 2019-01-24T10:11:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/CNS.jpg https://www.pharmaceutical-business-review.com/news/biontech-to-acquire-antibody-generation-unit-of-mab-discovery/ 2019-01-24T10:12:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/photo-1471864190281-a93a3070b6de.jpg https://www.pharmaceutical-business-review.com/news/gsk-oncology-tesaro-2/ 2019-01-24T10:13:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/gsk-house.jpg https://www.pharmaceutical-business-review.com/news/circassia-ait-airnovent-rights/ 2019-01-25T05:49:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/photo-1528789408128-bf8999ce0091-1.jpg https://www.pharmaceutical-business-review.com/news/navitor-pharmaceuticals-commences-phase-1-clinical-evaluation-of-nv-5138-for-treatment-resistant-depression/ 2019-01-25T05:50:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/depression.jpg https://www.pharmaceutical-business-review.com/news/x-rx-announces-fda-acceptance-of-ind-application-for-x-165/ 2019-01-25T05:51:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/bridgebio-pharma-drug-research/ 2019-01-25T07:20:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/druresearch.jpg https://www.pharmaceutical-business-review.com/news/clovis-rubraca-ovarian-cancer/ 2019-01-28T07:53:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Ovariancancer.jpg https://www.pharmaceutical-business-review.com/news/nextpharma-to-acquire-santens-tampere-manufacturing-facility/ 2019-01-28T09:28:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Santarn.jpg https://www.pharmaceutical-business-review.com/news/eib-to-lend-e100m-to-orion-for-pharmaceutical-research-and-development/ 2019-01-28T10:09:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/acf07869-af11-497e-b576-8e1c1e61f0a7.jpg https://www.pharmaceutical-business-review.com/news/destiny-pharma-xf-73-trial/ 2019-01-29T07:43:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100369068.jpg https://www.pharmaceutical-business-review.com/news/sobi-synagis-astrazeneca/ 2019-01-29T07:43:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Drug.jpg https://www.pharmaceutical-business-review.com/news/vertex-secures-health-canada-approval-for-expanded-use-of-kalydeco/ 2019-01-29T07:48:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100373814.jpg https://www.pharmaceutical-business-review.com/news/alexion-announces-phase-3-study-of-ultomiris-achieves-primary-objective-in-complement-inhibitor-naive-patients-with-ahus/ 2019-01-29T10:46:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Bloodcell.jpg https://www.pharmaceutical-business-review.com/news/lyndra-therapeutics-raises-55m-in-series-b-financing/ 2019-01-30T07:02:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/photo-1523006480666-4debbb34a28d.jpg https://www.pharmaceutical-business-review.com/news/takeda-tak-003-dengue-vaccine/ 2019-01-30T07:06:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/takeda.jpg https://www.pharmaceutical-business-review.com/news/fda-leukemia-imbruvica-obinutuzumab/ 2019-01-30T07:08:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Johnson.jpg https://www.pharmaceutical-business-review.com/news/pfizer-and-lilly-announce-top-line-results-from-second-phase-3-study-of-tanezumab-in-osteoarthritis-pain/ 2019-01-30T10:00:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/PfizerHQ.jpg https://www.pharmaceutical-business-review.com/news/shield-feraccru-aegis-ckd-study/ 2019-01-30T10:33:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100251774.jpg https://www.pharmaceutical-business-review.com/news/dewpoint-therapeutics-launches-with-60m-series-a-to-advance-proprietary-platform-for-drugging-condensates/ 2019-01-31T07:55:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/ID-100271789.jpg https://www.pharmaceutical-business-review.com/news/eureka-therapeutics-announces-us-fda-clearance-of-ind-application-for-trial-of-et140202-artemis-t-cell-therapy/ 2019-01-31T11:21:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Liverdisease.jpg https://www.pharmaceutical-business-review.com/news/15-valent-pneumococcal-vaccine/ 2019-02-01T08:13:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/genentech-crenezumab-trials-futility/ 2019-02-01T08:14:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/genetech.jpg https://www.pharmaceutical-business-review.com/news/hitachi-chemical-to-acquire-apceth-biopharma/ 2019-02-01T10:24:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-10097695.jpg https://www.pharmaceutical-business-review.com/news/fortress-biotech-announces-cael-101-strategic-partnership-with-alexion-pharmaceuticals/ 2019-02-04T06:30:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Strategic.jpg https://www.pharmaceutical-business-review.com/news/neuraxpharm-acquires-cns-specialty-pharma-company-farmax/ 2019-02-04T07:56:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/shaking-hands-1238535.jpg https://www.pharmaceutical-business-review.com/news/janssen-meiragtx-retinal-diseases/ 2019-02-04T08:09:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/jonson.jpg https://www.pharmaceutical-business-review.com/news/newron-completes-patient-enrollment-in-stars-study/ 2019-02-04T10:42:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/brainhuman.jpg https://www.pharmaceutical-business-review.com/news/chmp-keytruda-plus-chemotherapy/ 2019-02-05T07:42:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/verseon-ve-1902-phase-1/ 2019-02-05T07:45:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/in-the-lab-1-1251082.jpg https://www.pharmaceutical-business-review.com/news/forxiga-type-1-diabetes/ 2019-02-05T07:45:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Astratablet.jpg https://www.pharmaceutical-business-review.com/news/iqvia-launches-iqvia-biotech-dedicated-to-emerging-biotech-and-biopharma-industry/ 2019-02-05T09:57:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-100271789.jpg https://www.pharmaceutical-business-review.com/news/eisai-and-purdue-pharma-present-efficacy-and-safety-data-from-second-pivotal-phase-3-insomnia-study/ 2019-02-05T10:03:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Eisai_Head_Office.jpg https://www.pharmaceutical-business-review.com/news/roche-kadcyla-early-breast-cancer/ 2019-02-05T13:30:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/RocheBasel-1.jpg https://www.pharmaceutical-business-review.com/news/amprologix-wins-dhsc-backing-for-new-antibiotic/ 2019-02-06T07:36:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/800px-QuarryHouseLeeds.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-dosing-of-first-monoclonal-antibody-encoded-by-mrna-in-clinical-trial/ 2019-02-06T09:28:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/labtest.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-medi8897-regulatory/ 2019-02-07T07:36:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/gsk-merck-m7824/ 2019-02-07T07:40:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/gsk-house.jpg https://www.pharmaceutical-business-review.com/news/pci-pharma-services-announces-bottling-line-expansion-at-rockford/ 2019-02-07T11:09:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/PCI-expands-Bottling-capacity.jpeg https://www.pharmaceutical-business-review.com/news/frazier-healthcare-partners-launches-recida-therapeutics-to-develop-novel-therapeutics-for-serious-antibiotic-resistant-infections/ 2019-02-07T11:10:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/medicine.jpg https://www.pharmaceutical-business-review.com/news/sanofi-blood-disorder-cablivi/ 2019-02-08T08:19:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/ligand-announces-omniab-partnership-with-genagon-therapeutics/ 2019-02-08T10:59:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/drudiscovery.jpg https://www.pharmaceutical-business-review.com/news/tamrx-launches-to-develop-pipeline-of-immuno-oncology-products-for-treatment-of-cancers/ 2019-02-08T10:59:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/in-the-lab-1-1251082-1.jpg https://www.pharmaceutical-business-review.com/news/evotec-galapagos-enter-into-collaboration-in-fibrosis-field/ 2019-02-11T11:28:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/fiborsis.jpg https://www.pharmaceutical-business-review.com/news/samsung-bioepis-c-bridge-capital-to-develop-and-commercialize-next-generation-biosimilars-in-china/ 2019-02-11T11:28:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/tabletChina.jpg https://www.pharmaceutical-business-review.com/news/finch-cp101-recurrent-c-difficile/ 2019-02-12T08:34:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/FDA_Bldg.jpg https://www.pharmaceutical-business-review.com/news/abbvie-and-teneobio-announce-a-strategic-transaction-to-develop-a-new-treatment-for-multiple-myeloma/ 2019-02-12T08:39:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/04/AbbVieHQE_004.jpg https://www.pharmaceutical-business-review.com/news/neotx-therapeutics-announces-immuno-oncology-clinical-trial-collaboration-with-astrazeneca/ 2019-02-12T08:41:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/virus.jpg https://www.pharmaceutical-business-review.com/news/fda-incyte-gvhd-jakafi/ 2019-02-12T08:42:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/indivior-suboxone-generic-version/ 2019-02-13T08:46:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Gavel.jpg https://www.pharmaceutical-business-review.com/news/redx-rock2-potential-fibrosis/ 2019-02-13T08:49:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-10078509.jpg https://www.pharmaceutical-business-review.com/news/gileads-liver-selonsertib/ 2019-02-13T08:49:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Liver.jpg https://www.pharmaceutical-business-review.com/news/fda-takes-action-against-17-companies-for-illegally-selling-products-claiming-to-treat-alzheimers-disease/ 2019-02-13T10:47:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-ibm-to-integrate-blockchain-technology-into-clinical-trials/ 2019-02-13T10:47:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Boehringer-Ingelheim.jpg https://www.pharmaceutical-business-review.com/news/worlds-largest-pharmaceutical-firm-selects-valgenesis-to-standardize-corporate-validation-process-enterprise-level/ 2019-02-14T10:56:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/System.jpg https://www.pharmaceutical-business-review.com/news/mayne-pharma-launches-lexette-halobetasol-propionate-foam-0-05-in-the-us/ 2019-02-14T10:58:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/800px-Psoriasis2010a.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-and-lilly-announce-the-carolina-cardiovascular-outcome-trial-of-tradjenta-met-its-primary-endpoint-of-non-inferiority-compared-with-glimepiride/ 2019-02-15T07:40:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/fda-novartis-egaten-fascioliasis/ 2019-02-15T08:44:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/novartis-hq.jpg https://www.pharmaceutical-business-review.com/news/clinigen-us-rights-proleukin/ 2019-02-15T10:39:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/tower-with-surrounding-buildings-image.jpg https://www.pharmaceutical-business-review.com/news/vor-biopharma-receives-42m-funds-to-advance-development-of-cell-therapy-product-candidate-for-acute-myeloid-leukemia/ 2019-02-15T10:41:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/virus-1.jpg https://www.pharmaceutical-business-review.com/news/sk-arvelle-antiepileptic-cenobamate/ 2019-02-18T09:14:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/epileptic.jpg https://www.pharmaceutical-business-review.com/news/motif-bio-iclaprim-fda-update/ 2019-02-18T09:14:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/800px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/artificial-intelligence-can-predict-survival-of-ovarian-cancer-patients/ 2019-02-18T09:26:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/eric.jpg https://www.pharmaceutical-business-review.com/news/decipher-biosciences-announces-research-collaboration-with-dendreon-to-identify-genomic-drivers-of-patient-response-to-sipuleucel-t/ 2019-02-18T10:15:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/clinical-trial-generic-1.jpg https://www.pharmaceutical-business-review.com/news/bayer-vitrakvi-loxo-195-rights/ 2019-02-19T08:18:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/bayer-hq.jpg https://www.pharmaceutical-business-review.com/news/pfizer-mercks-bavencio-inlyta/ 2019-02-19T08:19:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/knight-signs-latin-american-strategic-funding-deal-with-moksha8/ 2019-02-19T10:55:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Knight.jpg https://www.pharmaceutical-business-review.com/news/innovent-chipscreen-biosciences-to-evaluate-combination-therapy-in-colorectal-cancer-patients/ 2019-02-19T10:56:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-100369076.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-melanoma/ 2019-02-20T07:57:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Keytruda-1.jpg https://www.pharmaceutical-business-review.com/news/bionomics-bnc21-ptsd-trial/ 2019-02-20T07:59:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/stress.jpg https://www.pharmaceutical-business-review.com/news/pfizer-receives-european-approval-for-zirabev-bevacizumab-a-biosimilar-to-avastin/ 2019-02-20T08:02:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Pfizernew.jpg https://www.pharmaceutical-business-review.com/news/innovation-pharmaceuticals-receives-new-patent-for-compounds-for-use-in-treatment-of-oral-mucositis/ 2019-02-20T11:01:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/mouth.jpg https://www.pharmaceutical-business-review.com/news/sosei-heptares-doses-first-patient-in-trial-targeting-endocrine-disorders/ 2019-02-21T09:46:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/stethotrial.jpg https://www.pharmaceutical-business-review.com/news/peloton-therapeutics-secures-150m-in-series-e-financing/ 2019-02-21T09:47:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-100588818.jpg https://www.pharmaceutical-business-review.com/news/ftc-teva-reverse-payment-charges/ 2019-02-21T09:47:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/750px-ApexBuildingHighsmith.jpg https://www.pharmaceutical-business-review.com/news/roche-entrectinib-polatuzumab-vedotin/ 2019-02-22T07:47:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Roche.jpg https://www.pharmaceutical-business-review.com/news/amgen-and-partners-begin-second-phase-3-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure/ 2019-02-22T11:16:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/01/Amgenheadquarters.jpg https://www.pharmaceutical-business-review.com/news/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration-with-janssen/ 2019-02-22T11:16:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/drugresearch.jpg https://www.pharmaceutical-business-review.com/news/indivior-generic-suboxone-opioid/ 2019-02-25T07:30:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/drug.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-and-accepts-sbla-of-soliris-as-treatment-for-nmosd/ 2019-02-25T09:28:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/urovant-sciences-signs-100m-debt-financing-agreement-with-hercules-capital/ 2019-02-25T09:29:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/DRug.jpg https://www.pharmaceutical-business-review.com/news/abbvie-voyager-gene-therapy/ 2019-02-26T05:36:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/AbbVieHQ.jpg https://www.pharmaceutical-business-review.com/news/merck-immune-design-300m/ 2019-02-26T05:37:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Immuno.jpg https://www.pharmaceutical-business-review.com/news/roche-acquisition-spark-therapeutics/ 2019-02-26T06:59:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/roche-location.jpg https://www.pharmaceutical-business-review.com/news/ipsen-acquisition-clementia/ 2019-02-26T07:00:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/mon-photo-1519120126473-8be7aedcd6c6.jpg https://www.pharmaceutical-business-review.com/news/novartis-to-pursue-transformational-therapy-to-reduce-risk-of-cardiovascular-disease/ 2019-02-26T09:12:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/brilintas-phase-3-themis-trial-met-primary-endpoint-in-patients-with-established-coronary-artery-disease-and-type-2-diabetes/ 2019-02-26T10:39:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/bausch-health-to-buy-certain-assets-of-synergy-pharmaceuticals/ 2019-02-27T10:59:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Baushhelat.jpg https://www.pharmaceutical-business-review.com/news/imbrium-therapeutics-and-tetragenetics-announce-strategic-research-collaboration-and-license-option-to-develop-novel-biologic-therapeutics-for-pain/ 2019-02-27T11:00:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-100271792.jpg https://www.pharmaceutical-business-review.com/news/cardiovascular-anthos-therapeutics/ 2019-02-28T08:10:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/novartis-hq-2.jpg https://www.pharmaceutical-business-review.com/news/danaher-ge-biopharma-21-4bn/ 2019-02-28T08:10:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Danaher.jpg https://www.pharmaceutical-business-review.com/news/nuformix-announces-mhra-approval-to-commence-nxp001-human-pharmacokinetics-studies/ 2019-02-28T11:07:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/drugpill.jpg https://www.pharmaceutical-business-review.com/news/axial-biotherapeutics-raises-25m-in-series-b-financing/ 2019-02-28T11:08:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/ID-100286441.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-xigduo-xr/ 2019-03-01T08:28:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/Astratablet-1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-herceptin-hylecta-for-subcutaneous-injection-in-certain-her2-positive-breast-cancers/ 2019-03-01T11:07:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/horizons-phase-3-trial-for-teprotumumab-in-active-thyroid-eye-disease-meets-primary-endpoint/ 2019-03-01T11:07:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-100220946.jpg https://www.pharmaceutical-business-review.com/news/gdnf-trial-parkinsons-disease/ 2019-03-01T11:10:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/getimage.jpg https://www.pharmaceutical-business-review.com/news/maze-therapeutics-genetic-insights/ 2019-03-04T06:30:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/tablet.jpg https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-announces-acquisition-of-raleigh-manufacturing-site/ 2019-03-04T10:54:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-10015908.jpg https://www.pharmaceutical-business-review.com/news/abpro-njcttq-partner-to-develop-multiple-bispecific-antibody-therapies/ 2019-03-04T10:54:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pill.jpg https://www.pharmaceutical-business-review.com/news/pfizers-lorviqua-marketing-authorization/ 2019-03-05T07:29:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/feraccru-phase-3-non-inferiority-study/ 2019-03-05T09:38:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/red-blood.jpg https://www.pharmaceutical-business-review.com/news/geovax-leidos-expand-collaboration-to-malaria-vaccines/ 2019-03-05T10:12:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/mosquito.jpg https://www.pharmaceutical-business-review.com/news/novartis-data-confirm-rapid-response-and-high-efficacy-of-cosentyx-in-psoriasis-patients-for-first-time-in-china/ 2019-03-05T10:13:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/novartisheadquar.jpg https://www.pharmaceutical-business-review.com/news/ensifentrine-dpi-phase-2-results/ 2019-03-06T07:57:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-100271789.jpg https://www.pharmaceutical-business-review.com/news/biogen-nightstar-therapeutics/ 2019-03-06T07:58:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Biogen.jpg https://www.pharmaceutical-business-review.com/news/ligand-sells-promacta-assets-and-royalty-for-827m/ 2019-03-06T11:04:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Ligand.jpg https://www.pharmaceutical-business-review.com/news/us-fda-grants-priority-review-for-fedratinib-new-drug-application-in-myelofibrosis/ 2019-03-06T11:04:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/FDAreseacrh.jpg https://www.pharmaceutical-business-review.com/news/ozempic-sustain-9-diabetes-trial/ 2019-03-07T08:36:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/NOVO_NORDISK_HQ-exterior-night-lowres2.jpg https://www.pharmaceutical-business-review.com/news/janssen-spravato-nasal-spray/ 2019-03-07T08:36:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/nasal.jpg https://www.pharmaceutical-business-review.com/news/imperial-college-says-hiv-remission-achieved-in-second-patient/ 2019-03-07T08:38:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/newseventsimage_1551726031575_mainnews2012_x1.jpg https://www.pharmaceutical-business-review.com/news/beam-therapeutics-secures-135m-funds-to-expand-pipeline-of-precision-genetic-medicines/ 2019-03-07T08:38:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/pharma.jpg https://www.pharmaceutical-business-review.com/news/gilead-announces-data-from-two-studies-supporting-further-development-of-investigational-hiv-1-capsid-inhibitor-gs-6207/ 2019-03-08T10:24:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/HIV.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-reports-positive-data-for-two-phase-3-hiv-trials-of-cabotegravir-rilpivirine-regimen/ 2019-03-08T10:25:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-10078506.jpg https://www.pharmaceutical-business-review.com/news/novartis-kinaxiss-rapidresponse-supply-chain/ 2019-03-08T13:11:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq.jpg https://www.pharmaceutical-business-review.com/news/roche-tecentriq-avastin/ 2019-03-11T07:51:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/roche-location.jpg https://www.pharmaceutical-business-review.com/news/gtx-oncternal-therapeutics-oncology/ 2019-03-11T07:54:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/cancer.jpg https://www.pharmaceutical-business-review.com/news/nallian-to-launch-global-pharma-tracker-early-adopter-program/ 2019-03-11T08:37:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/gpt-general.jpg https://www.pharmaceutical-business-review.com/news/taiwanj-pharmaceuticals-obtained-26m-deal-for-licensing-and-co-development-contract-with-newsoara-biopharma-on-jkb-122-asian-rights/ 2019-03-11T08:37:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/mar-11photo-1518169640858-0d622b058e5c.jpg https://www.pharmaceutical-business-review.com/news/nice-blood-cancer-blincyto/ 2019-03-11T08:38:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Virus.jpg https://www.pharmaceutical-business-review.com/news/clinical-stage-biotech-company-inventisbio-closes-70m-series-c-financing/ 2019-03-12T06:45:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/business-3152586_960_720.jpg https://www.pharmaceutical-business-review.com/news/tenax-therapeutics-recruits-first-patient-in-phase-2-pulmonary-hypertension-clinical-trial/ 2019-03-12T08:58:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pulmonary.jpg https://www.pharmaceutical-business-review.com/news/seres-astrazeneca-microbiome-oncology/ 2019-03-12T12:59:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/cq5dam.web_.1200.CGI-Aerial-View.jpg https://www.pharmaceutical-business-review.com/news/pfizer-oncology-biosimilar-trazimera/ 2019-03-13T08:07:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pfizerworld-1.jpg https://www.pharmaceutical-business-review.com/news/lillys-cyramza-meets-primary-endpoint-in-phase-3-relay-trial/ 2019-03-13T08:09:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-dupixent-for-moderate-to-severe-atopic-dermatitis-in-adolescents/ 2019-03-13T08:12:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/dupixent-fda-priority-review-crswnp/ 2019-03-13T08:13:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Photo2_1539896880300-HR.jpg https://www.pharmaceutical-business-review.com/news/bioarctic-announces-start-of-phase-1-study-of-abbv-0805-for-parkinsons-disease/ 2019-03-14T06:57:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/laboratory-768x512.jpg https://www.pharmaceutical-business-review.com/news/cancer-drug-parkinsons-patients/ 2019-03-14T07:45:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-100220917.jpg https://www.pharmaceutical-business-review.com/news/fujifilm-biogen-biologics-manufacturing/ 2019-03-14T07:53:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Biogen-1.jpg https://www.pharmaceutical-business-review.com/news/european-commission-approves-roches-hemlibra-for-people-with-severe-haemophilia-a-without-factor-viii-inhibitors/ 2019-03-15T09:12:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/RocheBasel.jpg https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-doses-first-patient-in-phase-2-trial-to-assess-ready-to-use-glucagon/ 2019-03-15T09:13:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/gluco.jpg https://www.pharmaceutical-business-review.com/news/merck-iktos-ai-technology/ 2019-03-18T08:27:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/AI-drug.jpg https://www.pharmaceutical-business-review.com/news/esperions-cholesterol-bempedoic-acid/ 2019-03-18T08:28:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Bempedoic.jpg https://www.pharmaceutical-business-review.com/news/biohaven-enrolls-first-patient-in-phase-3-spinocerebellar-ataxia-clinical-trial-of-troriluzole/ 2019-03-18T10:33:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/blood-20745_960_720.jpg https://www.pharmaceutical-business-review.com/news/european-commission-approves-roches-mabthera-for-rare-autoimmune-disease/ 2019-03-18T10:53:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Roche.jpg https://www.pharmaceutical-business-review.com/news/heart-drug-sudden-cardiac-arrest/ 2019-03-19T07:52:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/medicine-1851178_960_720.jpg https://www.pharmaceutical-business-review.com/news/blackstone-specialty-pharmaceutical-ayumi/ 2019-03-19T07:53:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Ayumi.jpg https://www.pharmaceutical-business-review.com/news/imara-closes-a-63m-series-b-cross-over-financing/ 2019-03-19T07:55:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/ono-enters-into-research-collaboration-agreement-with-twoxar/ 2019-03-19T11:18:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/tablet-2.jpg https://www.pharmaceutical-business-review.com/news/sage-therapeutics-postpartum-depression-zulresso/ 2019-03-20T08:03:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-settles-us-patent-litigation-case-on-victoza-liraglutide-with-teva/ 2019-03-20T08:05:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Danish-head.jpg https://www.pharmaceutical-business-review.com/news/genentech-tecentriq-chemotherapy/ 2019-03-20T08:09:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Genentech.jpg https://www.pharmaceutical-business-review.com/news/merck-kgaa-pfizer-discontinue-phase-iii-javelin-ovarian-parp-100-trial/ 2019-03-20T09:19:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pfizerworld-2.jpg https://www.pharmaceutical-business-review.com/news/epigenetic-protein-aml-study/ 2019-03-21T10:37:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Basheeretal.jpg https://www.pharmaceutical-business-review.com/news/mundipharma-launches-invokana-and-vokanamet-in-norway-for-treatment-of-type-2-diabetes/ 2019-03-21T10:37:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/mundipharma_3-472-of-478.jpg https://www.pharmaceutical-business-review.com/news/merck-ngm-bio-extend-multi-year-strategic-collaboration/ 2019-03-21T10:38:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/drug.jpg https://www.pharmaceutical-business-review.com/news/evotec-gardp-develop-antibiotics/ 2019-03-22T10:26:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/laboratory-3827738_960_720.jpg https://www.pharmaceutical-business-review.com/news/imago-biosciences-announces-40m-series-b-financing-led-by-omega-funds/ 2019-03-22T10:27:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Fri-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/conatus-announces-top-line-results-from-encore-nf-phase-2b-clinical-trial-in-nash-fibrosis/ 2019-03-22T10:28:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/liver.jpg https://www.pharmaceutical-business-review.com/news/anti-bcma-antibody-drug/ 2019-03-25T07:57:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/GSK.jpg https://www.pharmaceutical-business-review.com/news/pfizer-vivet-therapeutics/ 2019-03-25T07:58:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Pfizerworldhead.jpg https://www.pharmaceutical-business-review.com/news/bluebird-bio-opens-gene-and-cell-therapy-manufacturing-facility-in-north-carolina/ 2019-03-25T11:10:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/janssen-seeks-expanded-use-of-darzalex-combination-therapy-for-patients-with-newly-diagnosed-multiple-myeloma/ 2019-03-25T11:11:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/virus.jpg https://www.pharmaceutical-business-review.com/news/arch-oncology-raises-50m-series-b-financing/ 2019-03-26T06:47:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-forxiga-approved-in-europe-for-type-1-diabetes/ 2019-03-26T08:27:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Astratablet.jpg https://www.pharmaceutical-business-review.com/news/aimmune-peanut-allergy-drug-ar101/ 2019-03-27T07:37:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/nuts-1736520_960_720.jpg https://www.pharmaceutical-business-review.com/news/bayer-janssen-litigation-xarelto/ 2019-03-27T08:10:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Bayer.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-brammer-bio/ 2019-03-27T08:12:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Thermo.jpg https://www.pharmaceutical-business-review.com/news/abbvie-gets-japanese-approval-for-skyrizi-to-treat-plaque-psoriasis-generalized-pustular-psoriasis-erythrodermic-psoriasis-and-psoriatic-arthritis/ 2019-03-27T10:08:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Abbvie.jpg https://www.pharmaceutical-business-review.com/news/transgene-bioinvent-extend-collaboration-to-develop-multifunctional-oncolytic-viruses-for-treatment-of-solid-tumors/ 2019-03-27T10:32:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/evgens-sfx-01-stem-trial/ 2019-03-27T10:55:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/laboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/medpharm-to-develop-new-xf-drug-formulations/ 2019-03-28T06:48:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/test-214186_960_720.jpg https://www.pharmaceutical-business-review.com/news/silence-therapeutics-sln124/ 2019-03-28T08:04:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/ID-100277292.jpg https://www.pharmaceutical-business-review.com/news/novartis-multiple-sclerosis-mayzent/ 2019-03-28T08:05:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-forxiga-approved-in-japan-for-type-1-diabetes/ 2019-03-28T09:12:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/tablet-3.jpg https://www.pharmaceutical-business-review.com/news/cancer-research-uk-lifearc-ono-pharma-establish-new-drug-discovery-alliance/ 2019-03-29T09:42:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/lab_work_hero.jpg https://www.pharmaceutical-business-review.com/news/merck-invests-in-expansion-of-manufacturing-capacity-for-biotech-medicines/ 2019-03-29T09:43:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Merck-biotech.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-treatment-for-patients-with-non-radiographic-axial-spondyloarthritis/ 2019-03-29T09:43:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-of-revlimid-and-imnovid-based-triplet-combo-regimens-for-multiple-myeloma/ 2019-04-01T08:54:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/800px-Plasmacytoma_ultramini1.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-tudorza-pressair-snda-to-include-data-for-reduction-of-copd-exacerbations-and-hospitalizations/ 2019-04-01T09:15:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Tudor.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-icd-therapeutics/ 2019-04-02T07:53:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Boengher.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo/ 2019-04-02T07:54:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Researchdrug.jpg https://www.pharmaceutical-business-review.com/news/tevas-migraine-treatment-ajovy-receives-eu-approval/ 2019-04-02T08:06:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Ajovy.jpg https://www.pharmaceutical-business-review.com/news/puma-biotechnology-pierre-fabre-enter-into-license-agreement-to-develop-and-commercialize-nerlynx-in-europe/ 2019-04-02T08:10:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/medic-563423_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-selumetinib/ 2019-04-02T08:34:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Astra.jpg https://www.pharmaceutical-business-review.com/news/sangamo-pfizer-announce-phase-1-2-interim-data-for-investigational-hemophilia-a-gene-therapy/ 2019-04-03T08:30:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/que-oncology-launches-phase-2-trials-in-the-us/ 2019-04-03T08:37:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/wed-cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/roches-ipatasertib-breast-cancer-trial/ 2019-04-03T08:42:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Roche.jpg https://www.pharmaceutical-business-review.com/news/xencor-astellas-pharma-antibody/ 2019-04-03T09:14:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Astellas.jpg https://www.pharmaceutical-business-review.com/news/novartis-acquire-ifm-tre/ 2019-04-04T04:27:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/tower-with-surrounding-buildings-image-e1554206978498.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-announces-juluca-dolutegravir-rilpivirine-maintains-hiv-viral-suppression-at-148-weeks/ 2019-04-04T07:47:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/hiv-1903371_960_720.jpg https://www.pharmaceutical-business-review.com/news/cellectis-phase-1-trial-ucartcs1/ 2019-04-04T07:48:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/dna-1903318_960_720.jpg https://www.pharmaceutical-business-review.com/news/sandoz-resubmits-biosimilar-pegfilgrastim-application-to-us-fda/ 2019-04-04T08:14:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/twist-bioscience-and-lakepharma-form-strategic-collaboration-to-provide-antibody-discovery-and-development-services/ 2019-04-05T08:26:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/puma-biotechnology-expands-cohorts-in-phase-ii-summit-trial-of-neratinib/ 2019-04-05T08:31:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/tumor.jpg https://www.pharmaceutical-business-review.com/news/gilead-descovy-hiv-prophylaxis/ 2019-04-08T08:38:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/HIV-virus.jpg https://www.pharmaceutical-business-review.com/news/alnylam-sanofi-conclude-research-and-option-phase-of-2014-rnai-therapeutics-collaboration/ 2019-04-08T09:21:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/sanofi.jpg https://www.pharmaceutical-business-review.com/news/three-pharma-kickback-allegations/ 2019-04-08T09:26:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Judge.jpg https://www.pharmaceutical-business-review.com/news/pfizer-lung-cancer-vizimpro/ 2019-04-08T09:27:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-ready-to-infuse-infugem-in-the-us/ 2019-04-08T09:36:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/sun-pharma-corporate.jpg https://www.pharmaceutical-business-review.com/news/celltrion-iprogen-adcs-partnership/ 2019-04-08T14:07:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/monday-test-214186_960_720.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-hiv-dovato/ 2019-04-09T07:54:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/DOVA.jpg https://www.pharmaceutical-business-review.com/news/otitopic-pursues-additional-new-indication-for-dry-powder-inhalation-of-aspirin-as-treatment-for-nsclc/ 2019-04-09T08:53:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/headache-1540220_960_720.jpg https://www.pharmaceutical-business-review.com/news/alnylam-regeneron-collaboration-to-discover-develop-and-commercialize-rnai-therapeutics/ 2019-04-09T09:18:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/neuron.jpg https://www.pharmaceutical-business-review.com/news/nanology-enrolls-first-patient-in-phase-1-2-clinical-trial-of-nanodoce-to-treat-bladder-cancer/ 2019-04-10T08:02:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/cancer.jpg https://www.pharmaceutical-business-review.com/news/poxel-reports-positive-top-line-results-for-imeglimin-phase-3-trial-in-japan/ 2019-04-10T09:26:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/wed-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/janssen-symtuza-diamond-trial/ 2019-04-12T07:13:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/hiv-1903373_960_720.jpg https://www.pharmaceutical-business-review.com/news/amgen-evenity-osteoporosis/ 2019-04-12T07:14:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Amgenhead.jpg https://www.pharmaceutical-business-review.com/news/wockhardt-receives-us-fda-approval-for-cancer-drug/ 2019-04-12T10:36:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/moleculin-announces-agreement-with-emory-university-to-conduct-pediatric-brain-tumor-trial/ 2019-04-12T10:45:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/chemistry-1-1162205.jpg https://www.pharmaceutical-business-review.com/news/lynparza-advanced-breast-cancer-ec/ 2019-04-15T09:51:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-and-novo-nordisk-announce-intent-to-initiate-a-clinical-collaboration-in-nash/ 2019-04-15T10:17:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/09/Danish-head.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-announces-acquisition-of-anda-portfolio/ 2019-04-15T10:21:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/askbio-aav-gene-therapy-news/ 2019-04-16T07:31:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/dna-163466_960_720.jpg https://www.pharmaceutical-business-review.com/news/alnylam-initiates-illuminate-b-phase-3-pediatric-study-of-lumasiran-to-treat-primary-hyperoxaluria-type-1/ 2019-04-16T08:37:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Kidney.jpg https://www.pharmaceutical-business-review.com/news/allele-scm-lifescience-sign-joint-research-and-development-agreement-to-develop-ipsc-based-diabetes-treatment/ 2019-04-16T08:54:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/diabetes-2058045_960_720.png https://www.pharmaceutical-business-review.com/news/balversa-metastatic-bladder-cancer-fda/ 2019-04-17T07:04:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/catalent-paragon-bioservices/ 2019-04-17T07:55:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/CDMO.jpg https://www.pharmaceutical-business-review.com/news/ms-pharma-genepharm/ 2019-04-17T11:13:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/MSPharma.jpg https://www.pharmaceutical-business-review.com/news/novartis-bla-brolucizumab-wet-amd/ 2019-04-17T11:13:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/tower-with-surrounding-buildings-image-1-e1555414450872.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-neoimmunetechs-hyleukin-7-for-idiopathic-cd4-lymphocytopenia-treatment/ 2019-04-17T11:19:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/dndi-atomwise-collaborate-to-advance-drug-development-using-ai-for-neglected-diseases/ 2019-04-17T11:31:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/medicalpill.jpg https://www.pharmaceutical-business-review.com/news/labcorp-envigo-covance/ 2019-04-18T07:34:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Labcorp.jpg https://www.pharmaceutical-business-review.com/news/gilead-insitro-steatohepatitis/ 2019-04-18T07:35:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/liverdisease.jpg https://www.pharmaceutical-business-review.com/news/casi-pharmaceuticals-in-licenses-rights-to-novel-anti-cd38-monoclonal-antibody-program-from-black-belt-therapeutics/ 2019-04-18T11:08:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/malignancy.jpg https://www.pharmaceutical-business-review.com/news/sk-twoxar-nsclc/ 2019-04-18T11:09:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/NSlsc.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-duaklir-pressair-to-treat-chronic-obstructive-pulmonary-disease/ 2019-04-18T11:11:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/aqvida-phyton-receive-approval-from-edqm-for-aqvidas-paclitaxel-injectable-fdf/ 2019-04-22T09:23:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/viela-bio-receives-us-fda-breakthrough-therapy-designation-for-inebilizumab-to-treat-neuromyelitis-optica-spectrum-disorder/ 2019-04-22T11:29:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/USFDAdevice.jpg https://www.pharmaceutical-business-review.com/news/forbius-announces-first-patient-dosed-in-phase-2a-egfr-overexpressing-tnbc-trial-of-avid100/ 2019-04-23T09:48:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/virus.jpg https://www.pharmaceutical-business-review.com/news/pfizer-lillys-painkiller-tanezumab/ 2019-04-23T10:08:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Pfizer-1.jpg https://www.pharmaceutical-business-review.com/news/teva-launches-generic-version-of-vesicare-solifenacin-succinate-tablets-in-us/ 2019-04-23T10:43:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/1280px-TevaCanada2.jpg https://www.pharmaceutical-business-review.com/news/fulcrum-drug-losmapimod-gsk/ 2019-04-24T06:51:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/pharmadrug.jpg https://www.pharmaceutical-business-review.com/news/fsd-pharma-to-acquire-prismic-pharmaceuticals/ 2019-04-24T08:11:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FSD.jpg https://www.pharmaceutical-business-review.com/news/lilly-announces-sale-of-legacy-antibiotics-brands-and-manufacturing-facility-in-china/ 2019-04-24T10:59:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-pinlyta-renal/ 2019-04-24T11:00:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/knopp-biosciences-gets-fda-orphan-drug-designation-for-dexpramipexole-tp-treat-hypereosinophilic-syndrome/ 2019-04-25T08:09:12+00:00 https://www.pharmaceutical-business-review.com/news/kite-announces-plans-for-new-state-of-the-art-facility-to-expand-cell-therapy-production-capabilities/ 2019-04-25T08:19:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/dna-1903318_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/teva-enforce-program-fremanezumab/ 2019-04-25T10:30:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/800px-TevaCanada2.jpg https://www.pharmaceutical-business-review.com/news/lillys-taltz-phase-3-nr-axspa-trial/ 2019-04-25T10:30:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/aptorum-launches-smart-pharma/ 2019-04-26T02:06:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/mc_121818118.jpg https://www.pharmaceutical-business-review.com/news/teva-pharmaceuticals-usa-recalls-losartan-potassium-25mg-and-100mg-tablets-usp-sold-exclusively-to-golden-state-medical-supply/ 2019-04-26T08:13:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/tablet.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-yields-mixed-results-in-phase-3-keynote-062-trial/ 2019-04-26T09:13:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/gsk-vaccine-manufacturing-hamilton/ 2019-04-26T11:07:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/gsk-house.jpg https://www.pharmaceutical-business-review.com/news/navidea-announces-comparative-study-to-evaluate-tilmanocept-in-patients-with-tb/ 2019-04-29T08:14:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/test-214186_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizer-receives-positive-chmp-opinion-for-talzenna-for-patients-with-inherited-brca-mutated-locally-advanced-or-metastatic-breast-cancer/ 2019-04-29T10:21:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/gilead-selonsertib-nash-study/ 2019-04-30T05:49:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/LIver.jpg https://www.pharmaceutical-business-review.com/news/lynparza-receives-positive-chmp-opinion-for-brca-mutated-advanced-ovarian-cancer/ 2019-04-30T08:09:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/finch-therapeutics-receives-fast-track-designation-for-investigation-of-full-spectrum-microbiota-as-treatment-for-children-with-autism-spectrum-disorder/ 2019-04-30T09:52:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/luspatercept-maa-application/ 2019-04-30T10:52:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/red-blood-cells-3188223_960_720.jpg https://www.pharmaceutical-business-review.com/news/gsk-benlysta-pediatric-lupus/ 2019-04-30T10:53:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/GSK-head.jpg https://www.pharmaceutical-business-review.com/news/sandoz-enters-agreement-for-proposed-trastuzumab-biosimilar-to-treat-selected-her2-positive-cancer-tumors/ 2019-05-01T08:21:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/tumor.jpg https://www.pharmaceutical-business-review.com/news/iktos-janssens-small-molecule/ 2019-05-01T10:28:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/artificial-intelligence-3382507_960_720.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabotegravir-rilpivirine/ 2019-05-01T10:28:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/HIV.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-kalydeco-to-treat-eligible-infants-with-cystic-fibrosis/ 2019-05-01T10:33:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/takeda-research-facility-san-diego/ 2019-05-02T07:12:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/sandiego_1600x900_b.jpg https://www.pharmaceutical-business-review.com/news/tmunity-uc-san-francisco-collaborate-to-advance-tcr-t-cell-therapies-for-pediatric-cancers/ 2019-05-02T07:56:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/UCcancer.jpg https://www.pharmaceutical-business-review.com/news/exelixis-initiates-phase-3-trial-of-cabozantinib-in-advanced-renal-cell-carcinoma/ 2019-05-02T08:36:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-benevolentai-partnership/ 2019-05-03T07:25:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/AstraZenecaBenevolentAI.jpg https://www.pharmaceutical-business-review.com/news/amgen-syapse-enter-precision-medicine-collaboration-in-oncology/ 2019-05-03T07:59:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Amgenhead.jpg https://www.pharmaceutical-business-review.com/news/transgene-astrazeneca-enter-into-a-collaboration-for-invir-io-based-armed-oncolytic-immunotherapies/ 2019-05-03T10:54:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/qternmet-xr-approved-in-us-for-treatment-of-type-2-diabetes/ 2019-05-06T08:58:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Astratab.jpg https://www.pharmaceutical-business-review.com/news/pear-therapeutics-initiates-feasibility-study-to-treat-depressive-symptoms-in-people-with-multiple-sclerosis/ 2019-05-06T09:36:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/test-tubes-2-1494463.jpg https://www.pharmaceutical-business-review.com/news/gsk-innoviva-trelegy-ellipta/ 2019-05-06T09:38:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/GSK.jpg https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-dengvaxia-vaccine/ 2019-05-06T09:38:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Mosquito.jpg https://www.pharmaceutical-business-review.com/news/lundbeck-acquire-abide-therapeutics/ 2019-05-07T07:41:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Headquarters_4.jpg https://www.pharmaceutical-business-review.com/news/wuxi-apptec-pharmapace-clinical-research/ 2019-05-07T07:42:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Wuxi.jpg https://www.pharmaceutical-business-review.com/news/deals/ligand-acquires-milestone-and-royalty-rights-to-sb206-from-novan/ 2019-05-07T09:38:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/handshake-3298455_960_720.jpg https://www.pharmaceutical-business-review.com/news/pharmacyte-biotech-advances-manufacturing-process-for-clinical-trial-in-pancreatic-cancer/ 2019-05-07T10:25:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/mitosis.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-blood-cancer-calquence/ 2019-05-08T07:26:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/tabletAstra.jpg https://www.pharmaceutical-business-review.com/news/roche-kadcyla-fda-approval/ 2019-05-08T07:27:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/RocheBasel-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-vyndaqel-vyndamax-cardiomyopathy/ 2019-05-08T07:28:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizernewyork.jpg https://www.pharmaceutical-business-review.com/news/mercks-belsomra-c-iv-meets-primary-efficacy-endpoint-in-phase-3-trial/ 2019-05-08T11:17:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/brain-2546101_640.jpg https://www.pharmaceutical-business-review.com/news/european-commission-approves-lorviqu-for-certain-adult-patients-with-previously-treated-alk-positive-nsclc/ 2019-05-08T11:20:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/xencor-xmab23104-phase-1/ 2019-05-09T10:47:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizer-acquires-clinical-stage-biotech-therachon/ 2019-05-09T11:36:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerworld-1.jpg https://www.pharmaceutical-business-review.com/news/bms-opdivo-brain-cancer/ 2019-05-10T07:19:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/BMS.jpg https://www.pharmaceutical-business-review.com/news/novartis-takeda-xiidra/ 2019-05-10T07:20:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Novartis.jpg https://www.pharmaceutical-business-review.com/news/magenta-therapeutics-presents-updated-phase-2-clinical-data-on-mgta-456-cell-therapy/ 2019-05-10T10:42:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/document-3271743_640.jpg https://www.pharmaceutical-business-review.com/news/spectrum-announces-asset-purchase-and-license-for-immuno-oncology-platform/ 2019-05-10T10:53:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/business-3141342_1920.jpg https://www.pharmaceutical-business-review.com/news/pfizer-opens-new-biologics-clinical-manufacturing-facility-in-massachusetts/ 2019-05-13T09:38:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerworld-2.jpg https://www.pharmaceutical-business-review.com/news/novartis-gilenya-proves-superiority-over-glatiramer-acetate-in-relapsing-remitting-ms/ 2019-05-13T10:52:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/02/novartis-hq-2.jpg https://www.pharmaceutical-business-review.com/news/merck-announces-results-from-phase-2-trial-of-v114-in-infants/ 2019-05-13T12:14:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/image.jpg https://www.pharmaceutical-business-review.com/news/vifor-pharma-veltassa-ckd/ 2019-05-14T07:28:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/blood-sample.jpg https://www.pharmaceutical-business-review.com/news/lillys-cyramza-becomes-first-fda-approved-biomarker-driven-therapy-in-patients-with-hepatocellular-carcinoma/ 2019-05-14T08:52:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Lilly.jpg https://www.pharmaceutical-business-review.com/news/exelixis-collaborator-daiichi-sankyo-launches-minnebro-esaxerenone-tablets-in-japan/ 2019-05-14T09:21:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/tablets-3-1562059.jpg https://www.pharmaceutical-business-review.com/news/sunovion-sep-363856-fda-breakthrough/ 2019-05-14T10:02:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/1024px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/zymeworks-enters-its-first-zymelink-antibody-drug-conjugate-platform-licensing-agreement-with-iconic-therapeutics/ 2019-05-15T09:08:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/cancer.jpg https://www.pharmaceutical-business-review.com/news/elevatebio-biotechnology-holding-company/ 2019-05-15T10:17:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/BaseCamp_1.jpg https://www.pharmaceutical-business-review.com/news/celgene-pomalyst-kaposi-sarcoma/ 2019-05-15T10:17:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pomalyst.jpg https://www.pharmaceutical-business-review.com/news/allegro-announces-positive-results-of-ex-us-proof-of-concept-trial-with-alg-1007-for-dry-eye-disease/ 2019-05-15T10:23:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/her-eye-1502144.jpg https://www.pharmaceutical-business-review.com/news/meliors-tolimidone-phase2b-trial/ 2019-05-16T07:32:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/wed-test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizer-merck-bavencio-inlyta/ 2019-05-16T07:32:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerhq.jpg https://www.pharmaceutical-business-review.com/news/takeda-frazier-healthcare-collaborate-to-launch-phathom-pharmaceuticals/ 2019-05-16T08:04:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Takeda.jpg https://www.pharmaceutical-business-review.com/news/pfizers-abrocitinib-yields-positive-results-in-phase-3-moderate-to-severe-ad-trial/ 2019-05-16T10:58:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerhq.jpg https://www.pharmaceutical-business-review.com/news/roche-leukemia-venclexta-gazyva/ 2019-05-17T06:39:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Roche-Basel.jpg https://www.pharmaceutical-business-review.com/news/essa-pharma-to-acquire-realm-therapeutics/ 2019-05-17T09:33:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/writing-1149962_640.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-to-acquire-manufacturing-site-in-cork-ireland-from-gsk/ 2019-05-17T10:17:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/GSK.jpg https://www.pharmaceutical-business-review.com/news/ligand-licenses-ver250840-to-cumulus-oncology/ 2019-05-20T11:02:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/cancer-cells-541954_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/us-fda-approves-gattex-for-children-above-one-year-of-age-with-short-bowel-syndrome/ 2019-05-20T11:14:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/20MAy-Pharma.jpg https://www.pharmaceutical-business-review.com/news/abbvie-glioblastoma-trial-depatux-m/ 2019-05-21T07:18:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/AbbVie_Depatux-M_phase-3-trial.jpg https://www.pharmaceutical-business-review.com/news/fragmin-fda-approval-vte-pediatrics/ 2019-05-21T07:18:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-says-symbicort-as-anti-inflammatory-reliever-reduces-attacks-in-mild-asthma/ 2019-05-21T10:56:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/springworks-therapeutics-initiates-phase-3-trial-of-nirogacestat-in-desmoid-tumors/ 2019-05-21T11:36:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/cancer-cells-541954_960_720-2.jpg https://www.pharmaceutical-business-review.com/news/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract/ 2019-05-22T08:58:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/syringe.jpg https://www.pharmaceutical-business-review.com/news/lillys-mirikizumab-succeeds-in-phase-2-study-in-crohns-disease/ 2019-05-22T11:07:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/Eli-Lilly-headquarters.jpg https://www.pharmaceutical-business-review.com/news/wasdell-build-new-facility-ireland/ 2019-05-22T13:30:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/17OCA1.jpg https://www.pharmaceutical-business-review.com/news/merck-peloton-therapeutics/ 2019-05-23T07:27:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Therapeutic.jpg https://www.pharmaceutical-business-review.com/news/catalent-acquires-cdmo-paragon/ 2019-05-23T07:28:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/dna-163466_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-sorilux-for-adolescent-plaque-psoriasis/ 2019-05-23T10:08:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/cyclica-launches-new-multi-targeted-drug-design-technology-ligand-design/ 2019-05-23T11:05:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/thu-laboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/novartis-qvm149-phase-2-asthma/ 2019-05-24T06:48:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/tower-with-logo-through-branches-image.jpg https://www.pharmaceutical-business-review.com/news/amgen-nuevolution/ 2019-05-24T06:48:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Amgenhead-1.jpg https://www.pharmaceutical-business-review.com/news/ucsf-doses-first-patient-in-triple-combination-clinical-trial-of-oncosecs-tavo-epacadostat-and-keytruda/ 2019-05-24T08:42:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/bacteria.jpg https://www.pharmaceutical-business-review.com/news/nektar-therapeutics-launches-inheris-biopharma/ 2019-05-24T10:25:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/nek-laboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/knopp-reports-positive-preclinical-data-for-neonatal-epilepsy-drug-candidate/ 2019-05-27T10:45:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/epilepsy-623346_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-gene-therapy-to-treat-pediatric-patients-with-spinal-muscular-atrophy/ 2019-05-27T11:02:42+00:00 https://www.pharmaceutical-business-review.com/news/neuraxpharm-probiotic-europe/ 2019-05-28T09:57:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Neuro.jpg https://www.pharmaceutical-business-review.com/news/novartis-breast-piqray-fulvestrant/ 2019-05-28T09:57:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Novar.jpg https://www.pharmaceutical-business-review.com/news/gsk-shingles-vaccine-shingrix/ 2019-05-28T09:57:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/GSK-1.jpg https://www.pharmaceutical-business-review.com/news/teva-reaches-agreement-with-oklahoma-to-resolve-states-claims/ 2019-05-28T10:54:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/1280px-TevaCanada2.jpg https://www.pharmaceutical-business-review.com/news/last-patient-enrolls-in-phase-2-trial-with-transgenes-tg4010-nivolumab-chemotherapy-for-first-line-treatment-of-advanced-nsclc/ 2019-05-28T11:36:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/mitosis-1.jpg https://www.pharmaceutical-business-review.com/news/viela-bio-collaborates-with-hansoh-pharma-to-develop-and-commercialize-inebilizumab-for-autoimmune-diseases-and-hematologic-cancers-in-china/ 2019-05-29T09:21:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/autovirus.jpg https://www.pharmaceutical-business-review.com/news/celgene-revlimid-rituximab/ 2019-05-29T11:00:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/blood-cancer.jpg https://www.pharmaceutical-business-review.com/news/lyrica-phase-3-trial-pgtc-seizures/ 2019-05-29T11:04:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Pfizerworldheadquartersentrance-1.jpg https://www.pharmaceutical-business-review.com/news/juvenescence-launches-souvien-therapeutics-to-address-neurodegenerative-diseases/ 2019-05-29T11:05:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/High-Street-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/lilly-centrexion-cntx-0290/ 2019-05-30T08:39:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/1024px-2006_0219FirstFUJIFOLDER0012.jpg https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-quartz-study-of-new-investigational-inhaled-combination-treatment-meets-primary-and-key-secondary-endpoints/ 2019-05-30T09:36:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Novar-1.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gubra-to-develop-anti-obesity-peptide-poly-agonists/ 2019-05-30T10:32:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/800px-Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/santhera-idebenone-dmd-ema/ 2019-05-31T07:25:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/European_Commision.001_-_Brussel.jpg https://www.pharmaceutical-business-review.com/news/epizyme-submits-nda-to-us-fda-for-tazemetostat-to-treat-epithelioid-sarcoma/ 2019-05-31T08:54:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/vertex-to-submit-vx-445-tezacaftor-and-ivacaftor-regimen-for-global-regulatory-approvals-in-cystic-fibrosis/ 2019-05-31T10:48:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/1024px-ClubbingCF.jpg https://www.pharmaceutical-business-review.com/news/chiesi-santheras-raxone-rights/ 2019-06-03T07:06:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/business-3141342_960_720.jpg https://www.pharmaceutical-business-review.com/news/merz-xeomin-chronic-sialorrhea/ 2019-06-03T08:14:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/Merz.jpg https://www.pharmaceutical-business-review.com/news/kite-humanigen-to-evaluate-yescarta-lenzilumab-combo-in-relapsed-refractory-dlbcl/ 2019-06-03T11:06:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-is-only-immunotherapy-to-demonstrate-overall-survival-at-three-years-in-unresectable-stage-iii-non-small-cell-lung-cancer/ 2019-06-03T11:10:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Tabastra.jpg https://www.pharmaceutical-business-review.com/news/lantheus-nanomab-immuno-oncology/ 2019-06-04T07:11:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/virus-1812092_1280.jpg https://www.pharmaceutical-business-review.com/news/lynparza-delivers-72-orr-in-phase-3-solo3-trial-in-advanced-ovarian-cancer/ 2019-06-04T10:48:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-hospital-acquired-and-ventilator-associated-bacterial-pneumonia/ 2019-06-04T10:50:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/ec-approves-zynteglo-ttd/ 2019-06-05T01:27:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/blood-1813410_960_720.jpg https://www.pharmaceutical-business-review.com/news/kisqali-breast-cancer-phase-3-trial/ 2019-06-05T06:15:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Kisqali-Product-and-Packaging-2.jpg https://www.pharmaceutical-business-review.com/news/genentechs-xolair-chronic-rhinosinusitis/ 2019-06-05T06:15:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Genetech.jpg https://www.pharmaceutical-business-review.com/news/reata-pharmaceuticals-gets-orphan-drug-designation-for-bardoxolone-methyl-to-treat-adpkd/ 2019-06-06T09:00:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/cstone-secures-approval-in-china-for-clinical-trial-of-cs1001-blu-554-combo-for-hcc/ 2019-06-06T10:23:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/cancer-cells-541954_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/goldfinch-bio-initiates-phase-1-clinical-trial-of-gfb-887-for-kidney-disease/ 2019-06-07T06:55:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/goldfinch-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/venetoclax-obinutuzumab-cll-phase-3/ 2019-06-07T08:02:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/roche-location.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-emgality-headache/ 2019-06-07T08:02:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Eli-lilly.jpg https://www.pharmaceutical-business-review.com/news/novartis-presents-first-of-its-kind-histology-data-with-iscalimab/ 2019-06-07T10:25:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Novartis.jpg https://www.pharmaceutical-business-review.com/news/calquence-phase-3-cll-trial/ 2019-06-07T11:58:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/acucela-emixustat-stargardt-disease/ 2019-06-10T08:20:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Human-Eye.jpg https://www.pharmaceutical-business-review.com/news/nference-enters-into-rd-data-science-partnership-with-janssen/ 2019-06-10T10:59:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/artificial-intelligence-3382507_960_720.jpg https://www.pharmaceutical-business-review.com/news/protokinetix-achieves-primary-objective-safety-at-midpoint-of-clinical-trial/ 2019-06-10T12:14:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/diabetes.jpg https://www.pharmaceutical-business-review.com/news/vertex-exonics-therapeutics/ 2019-06-10T13:19:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Vertex.jpg https://www.pharmaceutical-business-review.com/news/merck-tilos-therapeutics/ 2019-06-11T07:30:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Tilo.jpg https://www.pharmaceutical-business-review.com/news/aptar-acquires-nanopharm-and-gateway-analytical-to-accelerate-customer-drug-development/ 2019-06-11T08:07:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Aptar.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-announces-positive-topline-results-from-phase-2b-study-of-ppc-06-in-moderate-to-severe-plaque-psoriasis/ 2019-06-11T11:10:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/theramex-bijuva-imvexxy-therapeuticsmd/ 2019-06-11T13:00:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Theramex-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/debiopharm-ipsen-extend-strategic-decapeptyl-partnership-for-another-15-years/ 2019-06-12T08:23:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/decap.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-psoriatic-arthritis/ 2019-06-12T08:35:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Novar.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-university-of-dundee-extend-anti-cancer-alliance/ 2019-06-12T11:00:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/800px-Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/keytruda-overall-survival/ 2019-06-12T11:35:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/genentech-polivy-brcombo-dlbcl-fda/ 2019-06-12T13:29:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/genetech-0081967.jpg https://www.pharmaceutical-business-review.com/news/vernalis-phoremost-announce-drug-discovery-collaboration-for-novel-oncology-target/ 2019-06-13T11:10:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/oncology.jpg https://www.pharmaceutical-business-review.com/news/pfizer-announces-results-from-xeljanz-xr-oral-shift-study/ 2019-06-13T11:18:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/dassault-medidata-solutions/ 2019-06-14T07:27:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/dassaluit.jpg https://www.pharmaceutical-business-review.com/news/keytruda-head-neck-cancer-fda/ 2019-06-14T07:28:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/corvidia-therapeutics-initiates-phase-2b-dose-finding-study-for-ziltivekimab/ 2019-06-14T10:49:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/kidney.jpg https://www.pharmaceutical-business-review.com/news/ibm-kpmg-merck-and-walmart-to-assess-use-of-blockchain-to-protect-pharmaceutical-product-integrity/ 2019-06-14T10:58:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/alexion-reports-positive-phase-3-extension-data-for-ultomiris-in-paroxysmal-nocturnal-hemoglobinuria/ 2019-06-17T10:49:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/alex-test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-to-sell-neurology-branded-products-to-upsher-smith-laboratories/ 2019-06-17T11:52:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Reddys.jpg https://www.pharmaceutical-business-review.com/news/tremfya-eclipse-trial-results/ 2019-06-17T14:29:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Tremfya-e1544686766749.jpg https://www.pharmaceutical-business-review.com/news/pfizer-array-biopharma/ 2019-06-18T07:25:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Pfizer-1.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-lokelma-esrd-trial/ 2019-06-18T07:28:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/tabletAstra.jpg https://www.pharmaceutical-business-review.com/news/janssen-guselkumab-psoriatic-arthritis/ 2019-06-18T08:21:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/12/Tremfya-e1544686766749.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ose-doses-first-patient-in-phase-1-trial-of-sirp%ce%b1-antagonist-monoclonal-antibody/ 2019-06-18T09:15:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Boengher.jpg https://www.pharmaceutical-business-review.com/news/mycovia-jiangsu-hengrui-to-develop-and-commercialize-antifungal-therapy-vt-1161/ 2019-06-18T10:51:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/china-laboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/amgen-rastuzumab-kanjinti/ 2019-06-19T04:52:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Amgenheadquat.jpg https://www.pharmaceutical-business-review.com/news/roche-gets-japanese-approval-for-personalised-medicine-rozlytrek/ 2019-06-19T08:56:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Roche.jpg https://www.pharmaceutical-business-review.com/news/victoza-fda-paediatric-approval/ 2019-06-19T10:15:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/NOVO_NORDISK_HQ-exterior-far-lowres2.jpg https://www.pharmaceutical-business-review.com/news/rocket-begins-patient-dosing-in-phase-1-trial-of-rp-a501-in-danon-disease/ 2019-06-19T10:51:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/dna-163466_960_720.jpg https://www.pharmaceutical-business-review.com/news/gamida-cell-lonza-establish-commercial-manufacturing-agreement-for-omidubicel/ 2019-06-20T08:12:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Bloodmarrow.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-lynparza-ovarian/ 2019-06-20T10:53:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Lyparenza.jpg https://www.pharmaceutical-business-review.com/news/ribomic-announces-positive-top-line-results-from-phase-1-2a-trial-of-rbm-007-in-wet-amd/ 2019-06-20T11:00:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/RIBOMICtest-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/linaclotide-phase-3b-trial-ibs-c/ 2019-06-21T08:09:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/linaclotide-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/horizon-therapeutics-initiates-mirror-trial-evaluating-krystexxa-in-combination-with-methotrexate/ 2019-06-21T09:45:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/tabletgout.jpg https://www.pharmaceutical-business-review.com/news/janssen-announces-collaboration-with-us-universities-to-expand-data-science-research-in-healthcare/ 2019-06-21T10:24:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/monitor-1307227_960_720.jpg https://www.pharmaceutical-business-review.com/news/alexion-ultomiris-ahus/ 2019-06-24T08:22:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/gilead-nurix-treatments-cancer/ 2019-06-24T08:23:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Gilead.jpg https://www.pharmaceutical-business-review.com/news/alnylam-announces-progress-with-rnai-therapeutics-platform/ 2019-06-24T10:49:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Oral.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-launches-phytonadione-injectable-emulsion-usp-10-mg-ml-single-dose-ampules-in-us/ 2019-06-24T11:42:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/bms-celgene-psoriasis-otezla/ 2019-06-25T07:04:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Bristol.jpg https://www.pharmaceutical-business-review.com/news/botox-fda-paediatric-approval-uls/ 2019-06-25T08:17:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/1024px-Allergan_headquarters.jpg https://www.pharmaceutical-business-review.com/news/pfizer-breast-cancer-talzenna/ 2019-06-25T08:17:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/gilead-carna-biosciences-collaborate-to-develop-novel-immuno-oncology-therapies/ 2019-06-25T09:01:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Gilead-1.jpg https://www.pharmaceutical-business-review.com/news/nantkwest-launches-phase-1-trial-with-targeted-pd-l1-t-hank-cell-therapy-in-patients-with-solid-tumors/ 2019-06-25T11:12:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/cancer-cells-541954_960_720-2.jpg https://www.pharmaceutical-business-review.com/news/tesaro-niraparib-fda-priority-review/ 2019-06-25T13:23:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/rafael-pharmaceuticals-ono-pharmaceutical-to-accelerate-clinical-development-of-cancer-drug-candidate-cpi-613/ 2019-06-26T10:27:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Ono.jpg https://www.pharmaceutical-business-review.com/news/imbrium-initiates-phase-2-study-of-imb-115-in-insomnia-associated-with-alcohol-cessation/ 2019-06-26T10:29:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/test-tubes-1-1494460.jpg https://www.pharmaceutical-business-review.com/news/tilt-123-avelumab-combo-trial/ 2019-06-27T07:41:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/tilt-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-empagliflozin-to-treat-chronic-heart-failure/ 2019-06-27T08:31:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/chronic-heart.jpg https://www.pharmaceutical-business-review.com/news/acceleron-completes-target-enrollment-in-phase-2-trial-of-sotatercept-in-pah/ 2019-06-27T11:35:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/heart-2222964_960_720-e1561635278373.png https://www.pharmaceutical-business-review.com/news/abbvie-allergan-irish/ 2019-06-28T07:40:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Allergan.jpg https://www.pharmaceutical-business-review.com/news/lung-cancer-drug-imfinzi-improves-overall-survival-at-interim-analysis-in-the-phase-iii-caspian-trial/ 2019-06-28T10:34:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/drug.jpg https://www.pharmaceutical-business-review.com/news/xeris-doses-first-patient-in-phase-2-trial-of-developmental-ready-to-use-glucagon-in-pbh/ 2019-06-28T10:45:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/ct-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/alexion-soliris-nmosd/ 2019-07-01T09:43:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Alextablet.jpg https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-dupixent-nasal/ 2019-07-01T09:43:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/chmp-recommends-eu-approval-of-roches-tecentriq-plus-abraxane-for-metastatic-tnbc/ 2019-07-01T10:25:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Roche.jpg https://www.pharmaceutical-business-review.com/news/sensorion-receives-ema-agreement-on-the-pediatric-investigation-plan-for-arazasetron-in-two-indications/ 2019-07-01T10:48:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/child-1439468_960_720.jpg https://www.pharmaceutical-business-review.com/news/puma-biotechnology-submits-snda-to-fda-for-neratinib-to-treat-her2-positive-metastatic-breast-cancer/ 2019-07-02T07:51:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/chmp-evenity-negative-opinion/ 2019-07-02T08:12:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Amgenheadquarters.jpg https://www.pharmaceutical-business-review.com/news/pfizer-avastin-biosimilar-zirabev/ 2019-07-02T08:12:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-enrols-first-patient-in-ve416-phase-1b-2-food-allergy-clinical-study/ 2019-07-02T10:29:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/ved-laboratory-3827745_960_720.jpg https://www.pharmaceutical-business-review.com/news/roche-flu-drug-xofluza/ 2019-07-03T07:39:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Roche-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-takeda-xiidra-2/ 2019-07-03T08:00:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Novartistower.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-yuhan-nash-molecule/ 2019-07-03T08:00:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries/ 2019-07-03T08:10:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Sandoz.jpg https://www.pharmaceutical-business-review.com/news/dicerna-to-begin-clinical-development-of-dcr-a1at-for-a1at-deficiency-associated-liver-disease/ 2019-07-03T10:26:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cli-test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-refractory-multiple-myeloma/ 2019-07-04T07:51:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/gsk-begins-phase-3-trial-for-otilimab-in-patients-with-rheumatoid-arthritis/ 2019-07-04T11:31:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/05/GSK-1.jpg https://www.pharmaceutical-business-review.com/news/fda-grifols-xembify-immunodeficiencies/ 2019-07-05T07:15:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/ec-viiv-healthcare-dovato/ 2019-07-05T07:15:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/HIVinfection.jpg https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-libtayo-ec-approval/ 2019-07-05T07:16:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/LibtayoProductShot_1524600959932-25-HR.jpg https://www.pharmaceutical-business-review.com/news/cantargia-announces-full-recruitment-of-can04-monotherapy-arm-in-ongoing-phase-iia-clinical-trial/ 2019-07-05T10:32:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/therapy.jpg https://www.pharmaceutical-business-review.com/news/valbiotis-announces-positive-results-from-phase-iia-trial-of-valedia-in-prediabetics/ 2019-07-05T10:36:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/vol-blood-17305_960_720.jpg https://www.pharmaceutical-business-review.com/news/phoremost-instem-enter-structural-biology-alliance/ 2019-07-08T10:34:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/drug.jpg https://www.pharmaceutical-business-review.com/news/ipsen-servier-announce-initial-phase-1-2-data-of-liposomal-irinotecan-in-metastatic-pancreatic-cancer/ 2019-07-08T11:21:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/fresenius-kabi-introduces-levothyroxine-sodium-injection-solution/ 2019-07-09T07:52:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Levo.jpg https://www.pharmaceutical-business-review.com/news/biondvax-phase-3-m-001-flu-vaccine/ 2019-07-09T09:25:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/vaccination-67477_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizer-sangamo-hemophilia-study/ 2019-07-09T09:26:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Pfizer-1.jpg https://www.pharmaceutical-business-review.com/news/lyndra-therapeutics-and-gilead-sciences-to-collaborate-on-development-of-ultra-long-acting-hiv-therapeutics/ 2019-07-09T11:06:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/gil-handshake-3298455_960_720.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-hiv-treatment/ 2019-07-10T07:53:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/HIVtreat.jpg https://www.pharmaceutical-business-review.com/news/morphosys-vivoryon-qpctl-inhibitors/ 2019-07-10T10:16:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/morp-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/celsius-therapeutics-signs-collaboration-agreement-with-janssen-to-identify-response-biomarkers-for-ulcerative-colitis/ 2019-07-10T10:54:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/jann-business-3141342_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-mercks-sbla-for-keytruda-six-week-dosing-schedule-for-melanoma-and-multiple-other-indications/ 2019-07-10T10:56:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-3.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-acquires-pre-clinical-pan-raf-inhibitor-program-from-redx-pharma/ 2019-07-11T08:13:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/program.jpg https://www.pharmaceutical-business-review.com/news/sanofi-isatuximab-fda-review/ 2019-07-11T10:04:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/altimmune-spitfire-pharma/ 2019-07-11T10:04:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Spitfire.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcares-phase-3-study-of-dolutegravir-plus-lamivudine-meets-primary-endpoint/ 2019-07-11T10:50:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/blood-20745_640.jpg https://www.pharmaceutical-business-review.com/news/novartis-amgen-alzheimers/ 2019-07-12T07:23:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Novarbuilding.jpg https://www.pharmaceutical-business-review.com/news/nexus-injectable-manufacturing-wisconsin/ 2019-07-12T07:23:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Nexus.jpg https://www.pharmaceutical-business-review.com/news/sotio-initiates-first-in-human-clinical-trial-with-il-15-superagonist-so-c101/ 2019-07-12T08:58:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cancerparticle.jpg https://www.pharmaceutical-business-review.com/news/gilead-renown-institute-for-health-innovation-announce-collaboration-to-advance-understanding-of-nash/ 2019-07-12T10:49:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/blood-17305_960_720.jpg https://www.pharmaceutical-business-review.com/news/sensorion-receives-fda-ind-approval-for-arazasetron/ 2019-07-15T10:00:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-4.jpg https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-ezallor-sprinkle-in-us-for-people-who-have-difficulty-swallowing/ 2019-07-15T10:46:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/08/sun-pharma-building.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-amal-therapeutics/ 2019-07-16T07:32:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/BoengherHD.jpg https://www.pharmaceutical-business-review.com/news/dicerna-gets-breakthrough-therapy-designation-for-dcr-phxc-to-treat-primary-hyperoxaluria-type-1/ 2019-07-16T08:53:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-5.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-fda-orphan-drug-status-sclc/ 2019-07-16T08:58:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cq5dam.web_.1200.AZ1572_Equipment.jpg https://www.pharmaceutical-business-review.com/news/gilead-galapagos-research-development/ 2019-07-16T08:59:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Gilead-deal.jpg https://www.pharmaceutical-business-review.com/news/recordati-to-acquire-worldwide-rights-to-signifor-and-osilodrostat/ 2019-07-16T11:07:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/tot-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/zejula-prima-trial-results/ 2019-07-17T07:30:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/22720111227_77ea5a925e_z.jpg https://www.pharmaceutical-business-review.com/news/abbvie-enhances-early-stage-oncology-pipeline-with-acquisition-of-mavupharma/ 2019-07-17T10:50:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Abbvie.jpg https://www.pharmaceutical-business-review.com/news/kite-to-bolster-cell-therapy-manufacturing-capabilities-with-new-viral-vector-facility/ 2019-07-17T10:54:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cancer-cells-541954_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-crizanlizumab-priority-review/ 2019-07-18T07:53:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/tower-with-logo-through-branches-image1-e1563344444794.jpg https://www.pharmaceutical-business-review.com/news/puretech-acquires-new-clinical-stage-programme-lyt-100-to-treat-lymphedema/ 2019-07-18T07:56:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Lymph.jpg https://www.pharmaceutical-business-review.com/news/ahf-calls-on-gilead-to-set-up-fund-for-victims-harmed-by-its-tdf-based-drugs/ 2019-07-18T11:11:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/law-1063249_960_720.jpg https://www.pharmaceutical-business-review.com/news/boehringer-bridge-biotherapeutics-ipf/ 2019-07-19T07:27:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/BoengherHD-1.jpg https://www.pharmaceutical-business-review.com/news/merck-recarbrio-complicated-infections/ 2019-07-19T07:31:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-6.jpg https://www.pharmaceutical-business-review.com/news/astellas-frequency-fx-322-deal/ 2019-07-19T07:33:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Astellas-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/lifemax-receives-rare-pediatric-disease-designation-for-lm-030-to-treat-netherton-syndrome/ 2019-07-19T11:12:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-6.jpg https://www.pharmaceutical-business-review.com/news/transgene-receives-mhra-approval-for-clinical-trial-of-next-generation-oncolytic-virus/ 2019-07-19T11:19:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Virusparticle.jpg https://www.pharmaceutical-business-review.com/news/novartis-multiple-sclerosis-product-gilenya-approved-in-china/ 2019-07-22T08:09:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Novartisdrug.jpg https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-announces-the-us-launch-of-generic-version-of-pregabalin-capsules/ 2019-07-22T11:01:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/medicine-2207622_960_720.jpg https://www.pharmaceutical-business-review.com/news/sandoz-recruits-first-patient-in-clinical-study-for-proposed-biosimilar-denosumab-in-osteoporosis/ 2019-07-23T07:55:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Osteotrial.jpg https://www.pharmaceutical-business-review.com/news/celgene-otezla-behcets-disease/ 2019-07-23T09:50:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-7.jpg https://www.pharmaceutical-business-review.com/news/janssen-subcutaneous-use-daratumumab/ 2019-07-23T09:56:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/darzalex-product-shot-e1563799573640.jpg https://www.pharmaceutical-business-review.com/news/acadia-announces-top-line-results-from-phase-3-schizophrenia-trial-of-pimavanserin/ 2019-07-23T11:18:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/sc-laboratory-3827745_960_720-e1563880668664.jpg https://www.pharmaceutical-business-review.com/news/jubilant-recalls-one-lot-of-drospirenone-and-ethinyl-estradiol-tablets/ 2019-07-24T07:57:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Blister.jpg https://www.pharmaceutical-business-review.com/news/ligand-acquires-ab-initio-biotherapeutics-an-antigen-discovery-company/ 2019-07-24T11:23:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/ligand-handshake-3298455_960_720.jpg https://www.pharmaceutical-business-review.com/news/viiv-fostemsavir-week-96-results/ 2019-07-24T11:27:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/viiv-blood-17305_960_720.jpg https://www.pharmaceutical-business-review.com/news/baxter-iv-insulin-myxredlin/ 2019-07-24T11:27:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/IVinsulin.jpg https://www.pharmaceutical-business-review.com/news/gemphire-therapeutics-and-neurobo-pharmaceuticals-announce-merger-agreement/ 2019-07-25T08:09:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/merger.jpg https://www.pharmaceutical-business-review.com/news/pfizer-roches-cancer-drug-rituxan/ 2019-07-25T08:32:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/keytruda-lenvima-fda-unresectable-hcc/ 2019-07-25T08:33:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-announces-positive-week-48-results-from-tango-study-of-dolutegravir-lamivudine/ 2019-07-25T11:07:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/viv-blood-17305_960_720.jpg https://www.pharmaceutical-business-review.com/news/epizyme-announces-fda-filing-acceptance-of-new-drug-application-and-priority-review-for-tazemetostat-to-treat-epithelioid-sarcoma/ 2019-07-26T08:52:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-8.jpg https://www.pharmaceutical-business-review.com/news/bms-lung-cancer-opdivo/ 2019-07-26T09:28:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/BMSfacility.jpg https://www.pharmaceutical-business-review.com/news/verastem-signs-license-deal-with-sanofi-for-copiktra-in-certain-countries/ 2019-07-26T11:16:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/neurovives-neurostat-project-receives-fda-fast-track-designation/ 2019-07-29T11:17:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/alvotech-and-cipla-gulf-enter-into-a-partnership-for-the-commercialization-of-key-biosimilar-in-select-emerging-markets/ 2019-07-29T11:20:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/cipla-business-3141342_960_720.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-submits-regulatory-application-to-ema-for-investigational-cabotegravir-to-be-used-in-combination-with-rilpivirine-for-hiv/ 2019-07-30T08:36:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/HIV-treat.jpg https://www.pharmaceutical-business-review.com/news/tecentriq-chemotherapy-combo-chmp/ 2019-07-30T09:30:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/roche-location.jpg https://www.pharmaceutical-business-review.com/news/zambon-breath-therapeutics/ 2019-07-30T09:31:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Zambon.jpg https://www.pharmaceutical-business-review.com/news/nec-acquires-norwegian-bioinformatics-company-oncoimmunity/ 2019-07-30T11:07:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/nec-cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/springworks-nf1-treatment-mirdametinib/ 2019-07-31T09:41:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Neuro.jpg https://www.pharmaceutical-business-review.com/news/keytruda-keynote-522-trial/ 2019-07-31T09:44:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/pfizers-upjohn-mylan/ 2019-07-31T09:46:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/sunovion-announces-acceptance-by-fda-of-nda-for-dasotraline-to-treat-binge-eating-disorder/ 2019-07-31T11:05:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-9.jpg https://www.pharmaceutical-business-review.com/news/pfizer-completes-acquisition-of-array-biopharma/ 2019-07-31T11:08:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/Pfizerworld.jpg https://www.pharmaceutical-business-review.com/news/verzenio-fulvestrant-monarch-2/ 2019-08-01T08:00:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/800px-2006_0219FirstFUJIFOLDER0012.jpg https://www.pharmaceutical-business-review.com/news/pfizer-announces-closing-of-jv-with-gsk-to-create-premier-global-consumer-healthcare-company/ 2019-08-01T08:01:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/exelixis-aurigene-strike-deal-to-discover-and-develop-novel-therapies-for-cancer/ 2019-08-01T11:02:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/gsk-asthma-treatment-nucala/ 2019-08-02T07:53:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/GSK-head.jpg https://www.pharmaceutical-business-review.com/news/kisqali-fulvestrant-monaleesa-3/ 2019-08-02T08:05:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Kisqali-Product-and-Packaging.jpg https://www.pharmaceutical-business-review.com/news/bayer-prostate-cancer-nubeqa/ 2019-08-02T08:05:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Nubeqa.jpg https://www.pharmaceutical-business-review.com/news/alvogen-lotus-launch-generic-version-of-navelbine-softgel-capsule-in-europe/ 2019-08-02T08:16:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Vino_launch.jpg https://www.pharmaceutical-business-review.com/news/kyowa-kirin-buys-back-tivozanib-non-oncology-rights-from-aveo-oncology/ 2019-08-02T08:56:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/kyowa-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/transgene-provides-update-on-phocus-study-of-pexa-vec-in-liver-cancer/ 2019-08-05T09:26:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/liver-3306256_640.jpg https://www.pharmaceutical-business-review.com/news/antikor-biopharma-and-essex-bio-technology-forge-strategic-alliance-in-fdc-for-cancer-treatment/ 2019-08-05T10:53:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/cancer-cells-541954_960_720-1.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-turalio-fda/ 2019-08-06T08:11:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/daiko-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/pfizers-rivipansel-phase-3-scd/ 2019-08-06T08:11:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Pfizerworldhead.jpg https://www.pharmaceutical-business-review.com/news/lilly-announces-positive-results-for-emgality-from-conquer-study/ 2019-08-06T09:08:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Eli.jpg https://www.pharmaceutical-business-review.com/news/hcl-technologies-and-oracle-health-sciences-collaborate-to-accelerate-mhealth-in-clinical-trials/ 2019-08-06T10:58:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/HCL_Tech_Noida_SEZ_Campus.png https://www.pharmaceutical-business-review.com/news/alnylam-givosiran-fda-priority-review/ 2019-08-06T13:03:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/aquinox-neoleukin-therapeutics/ 2019-08-07T07:45:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Neoleukin.jpg https://www.pharmaceutical-business-review.com/news/ontario-provides-access-to-biktarvy-for-treatment-of-hiv/ 2019-08-07T08:08:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Biktray.jpg https://www.pharmaceutical-business-review.com/news/stoke-therapeutics-granted-fda-orphan-drug-designation-for-stk-001-for-dravet-syndrome/ 2019-08-07T11:07:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/07/FDAdrug-9.jpg https://www.pharmaceutical-business-review.com/news/roches-tecentriq-chemotherapy-cancer/ 2019-08-07T12:47:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Roche-1.jpg https://www.pharmaceutical-business-review.com/news/lynparza-phase-iii-profound-trial-in-hrr-mutation-selected-metastatic-castration-resistant-prostate-cancer-met-primary-endpoint/ 2019-08-08T11:33:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Lyparanza.jpg https://www.pharmaceutical-business-review.com/news/vesselon-acquires-fda-approved-lipid-microsphere-drug-imagent-for-therapeutic-platform/ 2019-08-08T11:39:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/drugplat.jpg https://www.pharmaceutical-business-review.com/news/bayer-bluerock-therapeutics/ 2019-08-09T08:12:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Bluerock.jpg https://www.pharmaceutical-business-review.com/news/gsk-ebola-vaccines-sabin/ 2019-08-09T08:15:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Brentford_-_980_Great_West_Road_Middlesex_-_GSK_House_-_panoramio.jpg https://www.pharmaceutical-business-review.com/news/permira-small-molecule-cambrex/ 2019-08-09T08:16:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Pemira.jpg https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-receives-fda-complete-response-letter-for-kpi-121-0-25-nda/ 2019-08-09T11:25:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Dry-eye.jpg https://www.pharmaceutical-business-review.com/news/sesen-bio-reports-data-update-from-phase-3-trial-for-high-risk-non-muscle-invasive-bladder-cancer/ 2019-08-09T11:31:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/blood.jpg https://www.pharmaceutical-business-review.com/news/neoleukin-therapeutics-aquinox-pharmaceuticals-complete-merger-transaction/ 2019-08-12T10:41:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/hand.jpg https://www.pharmaceutical-business-review.com/news/ascletis-opens-clinical-development-shanghai-center/ 2019-08-12T11:18:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/syringe-1781353_960_720.jpg https://www.pharmaceutical-business-review.com/news/eidos-therapeutics-confirms-receipt-of-non-binding-proposal-from-bridgebio-pharma-to-acquire-shares/ 2019-08-13T10:22:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Bio.jpg https://www.pharmaceutical-business-review.com/news/sandoz-erelzi-patent-infringement/ 2019-08-13T10:30:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/tower-with-surrounding-buildings-image1-e1565610894576.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-tagrisso-lung-cancer/ 2019-08-13T10:30:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Luncancer.jpg https://www.pharmaceutical-business-review.com/news/kedrion-biopharma-announces-enrollment-of-first-patient-in-cares10-trial/ 2019-08-13T10:58:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/lab-3498584_960_720.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-anderson/ 2019-08-14T08:33:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-cavion/ 2019-08-14T08:33:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Jazz.jpg https://www.pharmaceutical-business-review.com/news/landos-biopharma-completes-49-7m-series-b-financing/ 2019-08-14T09:03:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/series-B.jpg https://www.pharmaceutical-business-review.com/news/lilly-announces-superiority-of-taltz-versus-tremfya-in-ixora-r-trial/ 2019-08-14T10:49:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Eli-lilly.jpg https://www.pharmaceutical-business-review.com/news/genecentric-therapeutics-acquires-select-immunogenomics/ 2019-08-16T08:12:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Gle.jpg https://www.pharmaceutical-business-review.com/news/european-medicines-agency-validates-marketing-application-for-filgotinib-for-the-treatment-of-rheumatoid-arthritis/ 2019-08-16T08:45:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Rheumatoid_Arthritis.jpg https://www.pharmaceutical-business-review.com/news/lynparza-plus-bevacizumab-paola-1/ 2019-08-19T06:08:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/10/Lynparza-e1539707982100.jpg https://www.pharmaceutical-business-review.com/news/janssen-new-indications-ibrutinib/ 2019-08-19T06:08:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/JandJ.jpg https://www.pharmaceutical-business-review.com/news/abbvie-receives-fda-approval-of-rinvoq-for-moderate-to-severe-rheumatoid-arthritis/ 2019-08-19T10:49:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/Abbvie.jpg https://www.pharmaceutical-business-review.com/news/xynomic-research-institute-successfully-designs-series-of-potent-ret-kinase-inhibitors/ 2019-08-19T10:53:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/pharmadrug.jpg https://www.pharmaceutical-business-review.com/news/angel-funded-siamab-completes-166m-exit-with-large-commercial-stage-biopharma/ 2019-08-20T07:50:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/virus.jpg https://www.pharmaceutical-business-review.com/news/celgene-myelofibrosis-inrebic/ 2019-08-20T08:05:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/roche-rozlytrek-ros1-nsclc/ 2019-08-20T08:05:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Roche.jpg https://www.pharmaceutical-business-review.com/news/knopp-begins-phase-2-trial-for-oral-dexpramipexole-in-eosinophilic-asthma/ 2019-08-20T10:34:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/knopptest-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/sanfer-cdpq-investment/ 2019-08-21T07:26:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/sanfer-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/fda-moderna-zika-vaccine/ 2019-08-21T07:26:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Zika.png https://www.pharmaceutical-business-review.com/news/fda-accepts-new-drug-application-for-elexacaftor-tezacaftor-and-ivacaftor-combination-treatment/ 2019-08-21T08:16:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/graybug-vision-secures-66m-to-advance-retina-and-glaucoma-clinical-programs/ 2019-08-21T10:45:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/risk-str-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-farxiga-heart-failure/ 2019-08-21T11:04:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Tarixga.jpg https://www.pharmaceutical-business-review.com/news/gsk-submits-first-regulatory-application-for-daprodustat-in-japan/ 2019-08-22T08:30:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/GSK-head-1.jpg https://www.pharmaceutical-business-review.com/news/mundipharma-announces-licence-extension-submission-for-invokana-and-vokanamet-to-ema/ 2019-08-22T10:37:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/mundipharma_3-472-of-478.jpg https://www.pharmaceutical-business-review.com/news/oncorus-series-b-funding/ 2019-08-22T11:53:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/onco-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/bayer-animal-health-elanco/ 2019-08-22T11:54:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/2014-9661.jpg https://www.pharmaceutical-business-review.com/news/pfizer-gene-therapy-facility/ 2019-08-23T07:51:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Pfizerworld-2.jpg https://www.pharmaceutical-business-review.com/news/finch-raises-43m-to-advance-microbiome-based-therapies-for-recurrent-cdi-autism-and-other-disease-areas/ 2019-08-23T10:48:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/finch-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/seelos-announces-fda-acceptance-of-ind-application-for-sls-005-for-sanfilippo-syndrome/ 2019-08-23T10:48:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/beyondsprings-plinabulin-demonstrates-superior-quality-of-life-in-phase-2-3-study-in-neutropenia/ 2019-08-26T04:21:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/beyond-red-blood-cells-3188223_960_720.jpg https://www.pharmaceutical-business-review.com/news/cabotegravir-rilpivirine-atlas-2m/ 2019-08-26T06:37:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/hiv-1903372_960_720.jpg https://www.pharmaceutical-business-review.com/news/cantargia-biowa-extend-ongoing-collaboration-around-potelligent-technology/ 2019-08-26T06:55:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/drug.jpg https://www.pharmaceutical-business-review.com/news/gilead-galapagos-deal-closing/ 2019-08-27T06:20:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/gil-business-3152586_960_720.jpg https://www.pharmaceutical-business-review.com/news/belantamab-mafodotin-multiple-myeloma/ 2019-08-27T06:20:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/GSK-head-2.jpg https://www.pharmaceutical-business-review.com/news/adc-therapeutics-and-freenome-enter-biomarker-development-collaboration/ 2019-08-27T07:25:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/tumor.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-appeal-opioid-judgment-in-oklahoma/ 2019-08-27T08:21:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/1024px-JohnsonJohnson_HQ_building.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-new-add-on-drug-to-treat-off-episodes-in-adults-with-parkinsons-disease/ 2019-08-28T11:08:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/onconano-awarded-12-6m-grant-from-cancer-prevention-and-research-institute-of-texas/ 2019-08-28T11:13:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/onco-cancer-cells-541954_960_720.jpg https://www.pharmaceutical-business-review.com/news/amgen-celgene-psoriasis-otezla/ 2019-08-29T05:42:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Amgenhead.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-lilly-taltz/ 2019-08-29T05:42:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/1024px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/emalex-biosciences-receives-fda-fast-track-designation-for-ecopipam-for-tourette-syndrome/ 2019-08-29T10:41:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/hifibio-therapeutics-closes-55m-series-c-financing/ 2019-08-29T10:48:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/integrity-agreement-3489902_960_720.jpg https://www.pharmaceutical-business-review.com/news/zogenix-acquire-modis-therapeutics/ 2019-08-29T12:47:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/dna-1811955_960_720.jpg https://www.pharmaceutical-business-review.com/news/springworks-therapeutics-gets-breakthrough-therapy-designation-for-nirogacestat-to-treat-desmoid-tumours/ 2019-08-30T10:41:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-2.jpg https://www.pharmaceutical-business-review.com/news/venatorx-initiates-enrollment-in-phase-3-trial-of-cefepime-vnrx-5133-in-cutis/ 2019-08-30T10:59:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/ven-medic-563423_960_720.jpg https://www.pharmaceutical-business-review.com/news/immatics-celgene-cancer-immunotherapies/ 2019-08-30T12:39:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/cel-mitosis-3876669_960_720.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-fasenra-eoe-odd/ 2019-09-02T02:51:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/roche-tecentriq-abraxane/ 2019-09-02T05:49:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Roche-1-1.jpg https://www.pharmaceutical-business-review.com/news/novartis-ofatumumab-rms-trials/ 2019-09-03T08:03:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/tower-with-surrounding-buildings-image1-1-e1567168633622.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-anifrolumab-sle/ 2019-09-03T08:03:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/Tarixga-1024x686-1.jpg https://www.pharmaceutical-business-review.com/news/entresto-improved-measures-of-heart-structure-and-function-in-hfref-patients-in-new-novartis-study/ 2019-09-03T11:14:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/03/novartis-hq-1.jpg https://www.pharmaceutical-business-review.com/news/valbiotis-announces-additional-positive-results-from-phase-iia-clinical-study-of-valedia/ 2019-09-03T11:17:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/tablet.jpg https://www.pharmaceutical-business-review.com/news/insilico-medicine-gentrl-ai/ 2019-09-04T06:44:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/artificial-intelligence-3382507_960_720.jpg https://www.pharmaceutical-business-review.com/news/roche-xofluza-flu-study/ 2019-09-04T06:44:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Roche-1.jpg https://www.pharmaceutical-business-review.com/news/impel-neuropharma-enrolls-last-patient-in-phase-3-migraine-trial-of-inp104/ 2019-09-04T11:06:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/impel-science-1029385_960_720.jpg https://www.pharmaceutical-business-review.com/news/deals/vertex-acquire-semma-therapeutics/ 2019-09-05T07:19:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/stem-business-3167295_960_720.jpg https://www.pharmaceutical-business-review.com/news/endo-announces-approval-of-first-generic-orfadin-in-us/ 2019-09-05T11:05:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/maruho-and-x-chem-announce-drug-discovery-collaboration/ 2019-09-05T11:11:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/maruho-handshake-3298455_960_720.jpg https://www.pharmaceutical-business-review.com/news/allergan-receives-fda-approval-of-juvederm-voluma-xc-for-mid-face-injection/ 2019-09-06T03:34:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/06/Allergan.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lupin-deal/ 2019-09-06T07:49:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/BIC_Flagge.jpg https://www.pharmaceutical-business-review.com/news/sungen-pharma-receives-seventh-anda-approval-from-us-fda/ 2019-09-06T10:59:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/veralox-therapeutics-raises-5-4m-in-seed-funding-co-led-by-jdrf-t1d-fund-and-sanofi-ventures/ 2019-09-06T11:04:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/vera-business-3152586_960_720.jpg https://www.pharmaceutical-business-review.com/news/sumitomo-dainippon-roivant-alliance/ 2019-09-10T07:57:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Dainippon_Sumitomo_Pharma.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheims-ofev-ssc-ild-fda/ 2019-09-10T07:57:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/3381a524-6b8f-4416-a14c-5f3db6b3f457.jpg https://www.pharmaceutical-business-review.com/news/horizon-secures-fda-priority-review-for-teprotumumab-for-treatment-of-active-thyroid-eye-disease/ 2019-09-10T10:18:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/08/FDAdrug-1.jpg https://www.pharmaceutical-business-review.com/news/acceleron-gets-fda-orphan-drug-designation-for-sotatercept-in-pulmonary-arterial-hypertension/ 2019-09-10T10:27:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDAdrug.jpg https://www.pharmaceutical-business-review.com/news/esketamine-nasal-spray-aspire/ 2019-09-11T08:27:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/esketamine.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi/ 2019-09-11T08:27:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/Astr.jpg https://www.pharmaceutical-business-review.com/news/avalon-ventures-and-coi-pharmaceuticals-announce-acquisition-of-sitari-pharmaceuticals-by-gsk/ 2019-09-11T09:23:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/GSK.jpg https://www.pharmaceutical-business-review.com/news/merck-initiates-phase-3-programme-for-evobrutinib-in-relapsing-multiple-sclerosis/ 2019-09-11T10:25:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/merck-test-214185_960_720.jpg https://www.pharmaceutical-business-review.com/news/xeris-gvoke-severe-hypoglycaemia/ 2019-09-12T08:10:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/09/FDA_Bldg_51_-_Main_Entrance_5161374834.jpg